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ABSTRACT
Obesity is the leading cause of chronic disease and has contributed to significant
health problems and complications. In order to solve this increasingly serious social
problem, it is particularly important to deepen the understanding of the biological causes
of obesity. Obesity is the result of an increased mass of adipose tissue after excessive
caloric intake, and adipogenesis is the main strategy through which the body increases the
number of adipocytes. However, due to the lack of research, the current understanding of
adipogenesis is not enough to yield results in the clinic.
The regulation of adipogenesis is complex, and the role of the Notch signaling
pathway in adipogenesis has long been controversial, as the role of individual Notch
receptors appears to vary with experimental conditions. In this dissertation, we
demonstrate that in human adipose-derived stem/stromal cells (hADSCs), Notch1 and
Notch3 have distinct expression profiles and roles during adipogenesis. Expression of
these Notch receptors changed during adipogenesis with Notch3 expressed prior to the
formation of lipid vesicles and Notch1 only appearing after vesicle formation. In
addition, the siRNA-mediated Notch3 knockdown demonstrated an increased expression
of PPARγ, an adipogenic marker, which was paralleled by a marked decrease in
expression of β-catenin, the key functional component of the canonical Wnt/β-catenin
signaling pathway. This study deepens the understanding of Notch signaling by clarifying
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the distinct roles of Notch1 and Notch3 during adipogenesis offering a novel therapeutic
target for research aimed at obesity and diabetes.
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INTRODUCTION

1.1
1.1.1

The Nature of Lipid Metabolism

Obesity
Obesity is a pathological result of the body storing surplus energy and

contributing to the mass of white adipose tissue (WAT). By increasing the body's
mechanical burden and causing a variety of chronic diseases, obesity significantly
reduces the quality of life and even increases the risk of death. Although the problem of
obesity can be solved through lifestyle changes, the increasing number of obese patients
proves that not everyone follows those guidelines. As long-term effective treatments have
not yet been identified, a better understanding of lipid metabolism has become a leading
course for research in recent years.
White adipocytes in WAT are mainly responsible for storing surplus triglycerides
(TGs) in lipid droplets. Therefore, under the condition of overnutrition, the mass of WAT
increases via two main paths: hyperplasia and hypertrophy. Hyperplasia is when the body
responds to surplus energy by increasing the number of white adipocytes. However, the
efficiency of hyperplasia becomes limited over time. As people age, additional nutritional
intake may cause the occurrence of hypertrophy, which is the increase in cell size that
results from adipocytes containing excess TGs. (Ghaben & Scherer, 2019; Klöting &
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Blüher, 2014). In general, hypertrophy is not an ideal strategy for energy storage since
the rapidly increased cell size affects the cellular oxygen uptake but does not actively
induce angiogenesis in the surrounding tissue. The unsatisfied oxygen consumption
directly forces adipocytes to start expressing fibrosis-related proteins resulting in fibrosis
of the surrounding tissue and corresponding local inflammation (Khan et al., 2009). The
hypoxia also triggers the endoplasmic reticulum stress and increases autophagy of
adipocytes (Klöting & Blüher, 2014). Finally, the increased cell volume has a positive
correlation with insulin resistance, further exacerbating the energy metabolism disorder
(Halberg et al., 2009).Therefore, a deeper understanding of the mechanism of hyperplasia
has important medical value for curbing the occurrence and consequences of
hypertrophy.

1.1.2

Adipogenesis
Hyperplasia relies on continued adipogenesis from adipocyte precursors.

Adipogenesis covers the entire process from stem cells to mature adipocytes and is
divided into two stages: commitment and terminal differentiation. Following adipogenic
induction, these fibroblast-like cells undergo additional replication until commitment is
initiated by cell contact. These multipotent precursors then become preadipocytes that are
restricted to the adipocyte lineage. Preadipocytes exit the cell cycle and subsequently
initiate terminal differentiation that requires excessive nutrition and the accumulation of
TGs in multiple micro lipid vesicles. A sufficient number of lipid vesicles then fuse into a
single lipid drop, thereby accomplishing the formation of mature adipocytes with a
spherical shape.
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At the molecular level, following commitment, the BMP2 and BMP4 signaling
cascades are activated to stimulate further differentiation (Figure 1-1) (Modica &
Wolfrum, 2017; E. A. Wang, Israel, Kelly, & Luxenberg, 1993). In addition, C/EPBP is
expressed to activate the transcription of C/EBP and PPAR. C/EBP and PPAR are
adipogenic master regulators as well as transcriptional activators of each other. This
positive feedback loop further stimulates the transcription efficiency of these two
molecules and the overall process of adipogenesis (MacDougald & Mandrup, 2002).
PPAR is a decisive nuclear receptor that controls the progress of adipogenesis, and its
expression is widely used as a marker of early adipogenesis. It has long been established
that PPAR is a master regulator of adipogenesis and that the absence of PPAR alone
prevents adipocyte differentiation (Rosen et al., 1999), while the activation of
PPAR only is sufficient to initiate the adipogenic program in fibroblasts (Tontonoz, Hu,
& Spiegelman, 1994). As a member of the nuclear receptor superfamily, PPAR
dimerizes with retinoid X receptor (RXR) and subsequently activates the transcription of
target genes, fabp4, lpl, gk, and aqp7 to regulate aspects of adipogenesis including
nutrient intake, insulin sensitivity, fat accumulation, and transport (de sá, Richard, Hang,
& Stephens, 2017; Koppen & Kalkhoven, 2010). Finally, in the process of maturation,
cells gradually initiate and increase the expression of adipokines such as adiponectin and
leptin to regulate physiological progress. Therefore, PPAR, FABP4, LPL, adiponectin,
and leptin are often used as indicators of late adipogenesis.

4

Figure 1-1: hADSC adipogenesis in vitro. hADSCs undergo commitment and
terminal differentiation to become mature adipocytes after the induction of adipogenic
media. The key molecular changes are shown above, and cell morphology changes are
shown below.

1.2
1.2.1

Cell Types for in vitro Study of Adipogenesis

In vitro Adipogenic Induction
In vivo and in vitro experiments are the most utilized means of studying fat

differentiation. Among these, in vivo experiments often focus on validating the
integrative biological effects of a particular molecule or treatment on lipid metabolism in
the whole living organism. Due to limitations such as high cost and long life cycle of
animal models, it is difficult to repeat a large number of in vivo experiments required in a
short period of time to deepen the understanding of adipogenic differentiation. Moreover,
because of the complexity of regulation of adipogenic differentiation and metabolism in
living organisms, mining specific regulatory mechanisms with in vivo studies becomes
challenging. Correspondingly, in vitro experiments that rely on adipose precursors or
stem cells are widely performed as a simplified version of in vivo experiments to expose

5
the mechanisms at a molecular level. Due to the advantages of easy manipulation,
induction of differentiation, and expansion of cell samples, the number of reports on in
vitro adipogenic differentiation and metabolism have increased over the years.
Although it is challenging to fully mimic the physiological conditions of in vivo
adipogenesis, years of research have reached some consensus on in vitro conditions to
induce adipogenesis of cellular precursors. The most commonly used chemical and small
molecule cocktails used to induce adipogenesis consist of fetal bovine serum (FBS),
isobutylmethylxanthine (IBMX), dexamethasone, and insulin. FBS provides a basic
source of nutrients for cell survival; IBMX elevates the level of cyclic adenosine
monophosphate (cAMP); dexamethasone is the ligand for the glucocorticoid receptor
(GR), a nuclear hormone receptor that promotes the expression of PPAR and C/EBP
families; and insulin which promotes the efficiency of nutrient intake to accelerate lipid
accumulation (Novakofski, 2004). Under such in vitro induction conditions, adipose
precursor cells are capable of undergoing major morphological and molecular processes
of in vivo adipogenesis.

1.2.2

Murine-Derived Cell Lines
To study in vitro adipogenesis, several murine cell lines have been established.

For instance, two cell lines were developed from mice to facilitate the study of
adipogenesis: C3H10T1/2 and 3T3. The C3H10T1/2 cell line was established from C3H
mouse embryonic stem cells to study the commitment of adipogenesis (Ruiz-Ojeda,
Rupérez, Gomez-Llorente, Gil, & Aguilera, 2016). Another two murine Swiss 3T3 cells
were used to develop committed pre-adipose cell lines, 3T3-L1 and 3T3-F442A, both of
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which are often used to study the differentiation process after commitment (Green &
Kehinde, 1974, 1976). Murine-derived cell lines have been utilized for decades, but as a
number of applications proven in mouse models then failed in human trials, establishing
human cell lines became essential for the study of human adipogenesis (Uhl & Warner,
2015).

1.2.3

Human Adipose-Derived Stromal/Stem Cells
The discovery and successful isolation of adult human stem cells provides

favorable conditions for studying human cell activity in vitro. Human adipose-derived
stem cells (hADSCs) are widely used adult stem cells due to their multipotency,
immunosuppressive effect, and ease of in vitro culture and manipulation (Ruiz-Ojeda et
al., 2016). Because hADSCs are directly isolated from donor adipose tissues, hADSCs
also have the advantages of easy isolation, abundance, and a small burden on donors. It is
noteworthy that the homogeneity of isolated hADSCs can vary due to the complexity of
the adipose tissue. Therefore, hADSCs are more often called human adipose-derived
stromal/stem cells to expand the scope of adaptation.
Since the natural role of hADSCs is to maintain the level of adipocytes in WAT
via adipogenesis, they are considered to be the most representative cell line for studying
the complete process of human fat differentiation (Cawthorn, Scheller, & MacDougald,
2012). However, due to the individual differences of donors and the physiological
differences of WAT from different parts of body, some outcomes resulting from the study
of hADSCs do differ. For instance, hADSCs from aged donors appear to have a weaker
capacity for adipogenic differentiation (Kawagishi-Hotta et al., 2017), while
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subcutaneous WAT-isolated ADSCs are more sensitive to adipogenic induction than
those cells isolated from visceral WAT (Macotela et al., 2012). These differences
contribute to questions about the reliability of using hADSCs in certain types of
experiments. However, when donor information is provided, different donor samples can
be used to study the characteristics of adipogenesis in the presence of different genetic
traits and metabolic-related diseases by comparing the characteristics of hADSCs from
different donors. Therefore, as long as researchers accurately represent and characterize
the source and properties of hADSCs used in their studies, hADSCs provide a valuable
and commonly used human cell type for studying the process of adipogenesis.

1.3
1.3.1

Notch Signaling Pathway

Notch Signaling pathway
First identified and defined by Tomas Hunt Morgan in 1917 (Morgan, 1917),

Notch remains one of the most critical pathways in the processes of cell proliferation,
differentiation, metabolism, and apoptosis. The role of Notch in regulating adipogenesis
was first published in 1997 (Garcés et al., 1997). However, because of the large number
of contradictory outcomes, more than two decades of continuous research have still not
provided a clear role for Notch in adipogenesis. Therefore, a deeper understanding is
crucial to the advancement of research in this field.
Notch is a highly conserved contact-dependent signaling pathway composed of
ligands, receptors, and downstream protein and genomic targets. As Figure 1-2 shows,
the Notch receptor stays inactivated on the surface of the membrane of the signalreceiving cell until it binds to a ligand located on the surface of an adjacent cell (signal-
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sending cell). The Notch receptor then releases its activated form, the Notch intracellular
domain (NICD), into the cytoplasm following the completion of two cleavages mediated
by a disintegrin and metalloproteinase domain 17 (ADAM17) metalloproteinase and the
γ-secretase complex. Without the activation of Notch, the transcription of Notch target
genes remains repressed by the inactive CBF1/Su(h)/LAG-1 (CSL) complex. When the
NICD is translocated into the nucleus, the CSL complex becomes activated and Notch
targets such as Hairy/Enhancer of split (Hes) and basic helix-loop-helix (bHLH)-type
transcriptional repressors (Hey) are transcribed to regulate cell fate.

Figure 1-2: The activation of the Notch signaling pathway. DSL= Delta-Serrate-Lag2
region of Notch ligands, NICD= Notch intracellular domain, CSL=
CBF1/Su(h)/LAG-1 (CSL) complex, and MAML= mastermind-like transcriptional
co-activator; S1, S2, and S3 represent the first, second, and third proteolytic cleavage,
respectively.
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1.3.2

Components of the Notch Pathway

Notch receptors
In mammals, there are four Notch receptors (Notch1-4), which all share the basic
structure of a single transmembrane receptor including a Notch extracellular domain
(NED), a transmembrane (TM) region, and a Notch intracellular domain (NICD) (Figure
1-3 A). The NED is the ligand binding domain and contains a number of epidermal
growth factor (EGF)-like repeats, ranging from 29 to 36 in different receptors, that
ultimately determine the affinity of the NED for specific ligands. The Notch Negitive
Regulatory Domain (NRR) is composed of three juxtamembrane Lin Notch Repeats
(LNRs) along with a heterodimerization domain (HD) and the cleavage site for ADAM
metalloprotease. The NICD is the main functional unit of the Notch receptor and is
composed of an Rbp-associated molecule domain (RAM), seven ankyrin (ANK) repeats,
and a degradation region consisting of Proline, Glutamic acid, Serine, and Threonine-rich
residues (PEST). In addition, Notch1 and Notch2 have a transactivation domain (TAD)
between the ANK repeats and PEST domain, but the function of a similar region in the
Notch3 and Notch4 receptors remains unknown (Siebel & Lendahl, 2017).
Notch ligands
There are two types of Notch ligands: canonical and non-canonical. Canonical
ligands include Delta-like (Dll) 1, 3, and 4, and Jagged (Jag) 1 and 2 which belong to the
Delta-Serrate-Lag2 (DSL) superfamily (Figure 1-3 B). These single trans-membrane
ligands consisit of a DSL region and EGF-like repeats in the extracullar domain for
ligand-receptor connection. Jag1 and 2 also have von Willebrand factor type C (vWFC)
domains and Jagged Serrate domains (JSD) following the EGF repeats. Non-canonical
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Notch ligands include delta-like non-canonical ligand (Dlk) 1 and 2, which are
structurally similar. Unlike the canonical ligands, the non-canonical ligands have an
additional cleavage site for ADAM17 and the extracellular domain of mature ligands is
not membrane bound. Therefore, these soluble ligands are capable of traveling and
binding to receptors on non-adjacent cells (D’Souza, Meloty-Kapella, & Weinmaster,
2010).

Figure 1-3: Structural illustration of Notch receptors and canonical ligands. The left
side of the cell membrane indicates the extracellular region, and the right side
illustrates the intracellular region. The number of EGF repeats in the extracellular area
is calibrated numerically. The figure was generated based on the information from the
literature review by Siebel et al. (Siebel & Lendahl, 2017).
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CSL complex
CSL, also referred to as recombination signal binding protein for immunoglobulin
kappa J region (RBP-J) in Homo sapiens, is composed of the LAG1-DNA binding
region, the beta-trefoil domain (BTD), and the IPT-RBP-Jk domain (E. C. Lai, 2002).
The early model stated that, without NICD, the CSL complex constitutively binds to
target DNA sequences to block transcription by recruitment of co-repressors. The RAM
and ANK region of NICD then recognize and bind to BTD and IPT-RBP-J respectively
to replace co-repressors on CSL and recruit the transcriptional co-activator Mastermind
(MAM) to form a new stabilized complex, which functions as a transcriptional activator.
Early research focused on canonical Notch transcription targets such as members of
the Hes and Hey families, but the study of these targets alone is not enough to cover all
the regulatory effects of Notch. Therefore, an increasing number of studies have started
to reveal non-canonical Notch transcription targets such as myc and fabp4 to expand the
scope of transcriptional regulation by Notch (Harjes, Bridges, McIntyre, Fielding, &
Harris, 2014; Palomero et al., 2006). In addition, the continuous exploration of the
regulatory potential of CSL is another key to deepening our understanding of the Notch
pathway and its role in human health and disease.
Early research on Notch was limited to canonical pathways, meaning that although
each Notch receptor has their own structural differences, their functions are generally
considered to be mutually redundant because Notch receptors activate the same CSL
complex. However, increasing evidence has proven that each of the four Notch receptors
has its own independent function. Therefore, simply uncovering the interaction between
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Notch receptors and CSL complex may be not enough to explain the unique role of Notch
receptors in development and disease.

1.3.3

The activation of Notch receptors

Since signaling amplification has not been observed in the study of the canonical
Notch pathway, the role of Notch remains highly determined by the method of activation,
typically the ligand-receptor interaction. However, due to the differences in ligands and
the different ways in which ligands bind to a given receptor, the activation of the Notch
signaling cascade is a highly complex process (Figure 1-4) (Bray, 2016).
Trans-activation
Trans-activation of the Notch pathway refers to the interaction of Notch receptors
with canonical ligands on neighboring cells (Figure 1-4 A). When a Notch ligand and a
receptor are respectively expressed in adjacent cells, the ligand on the signal-sending cell
specifically binds to the Notch receptor located on the surface of the signal-receiving cell.
The signal-sending cell then pulls the ligand-receptor complex by endocytosis to expose
the cleavage sites of the receptor to the ADAM metalloprotease and the γ-secretase. Since
the physical force on the receptor is the key for subsequent cleavage events, simple
ligand-receptor binding does not activate the pathway but instead inhibits the pathway by
occupying the receptor. For instance, in vitro experiments showed that the addition of
Jagged1 only activated the Notch pathway when Jagged1 was present and physically
attached to the culture dishes, whereas it appeared to inhibit Notch activity when Jagged1
protein was present in suspension and dissolved in the culture media.
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Cis-inhibition
The cis-binding of the Notch receptor and canonical ligand has been reported in
cases where both the ligand and receptor are expressed by the same cell (Figure 1-4 B).
Because the direction is opposite to that of trans-binding, the endocytosis of the ligand
cannot provide a pulling force to the receptor, resulting in an inactivated receptor. In
addition, it has been hypothesized that the trans- and cis-binding sites overlap, and the
cis-interaction has higher affinity so that cis-bound ligand-receptor complexes are stable
enough to block the trans-activation.
Interactions with non-canonical Notch ligands
As described, non-canonical Notch ligands, Dlk1 and Dlk2, are not cell bound so
that these two ligands have similar roles to soluble canonical ligands (Figure 1-4 C). The
complex formed with a Notch receptor and non-canonical ligand does not generate
cleaved NICD because there is no force to expose the cleavage site of the Notch receptor.
In other words, Dlk1 and Dlk2 are negative regulators of Notch. It is reported that Dlk1,
also known as preadipocyte factor 1 (Pref1), inhibits cell lipid synthesis by binding to and
inhibiting the function of Notch1 (Kilian, Klöting, Blüher, & Beck-Sickinger, 2016).
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Figure 1-4: Interactions of Notch receptors and ligands. A. Receptors and ligands
expressed in different cells release NICD through trans-activation. B. Receptors and
ligands expressed in the same cell prevent the release of NICD through cis-inhibition.
C. Non-canonical ligands bind but do not activate receptors.

1.4
1.4.1

Notch and Adipogenesis

Notch pathway and adipogenesis
The negative effect of the Notch pathway on adipogenesis has been demonstrated

by multiple studies across different cell lines. For instance, it has been reported that the
inhibition of Notch using a -secretase inhibitor (GSI) promoted adipogenesis as
indicated by the increased expression of PPARγ and accumulation of lipid vesicles in
BMSCs, hADSCs, and mADSCs (Huang et al., 2010; Osathanon, Subbalekha,
Sastravaha, & Pavasant, 2012; B. Song et al., 2015; Vujovic, Henderson, Flanagan, &
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Clements, 2007). On the other hand, the activation of Notch was also triggered by the
overexpression or tissue culture dishes coated in Notch ligand Jagged1. Finally,
suppressed adipogenesis was also observed in hADSCs, hBMSCs, and 3T3-L1
preadipocytes (Osathanon et al., 2012; Ross, Rao, & Kadesch, 2004). Therefore, multiple
in vitro studies have provided a consensus for the negative role of Notch in adipogenesis.

1.4.2

Canonical regulation of Notch to adipogenesis

Hes1 and adipogenesis
In order to gain a deeper understanding of the mechanism by which Notch inhibits
adipogenesis, several Notch canonical targets such as Hes1 and Hey1 have become the
primary subject of on-going research. Indeed, Hes1 has been demonstrated to suppress
adipogenesis by blocking the transcription of ppar (Herzig et al., 2003). Since PPAR is
essential for fat differentiation, early research suggested that Hes1 was the key molecule
for Notch to inhibit adipogenesis, and additional experiments were conducted to
determine the relationship between Notch receptors, Hes1, and PPAR However,
subsequent research has revealed that the role of Hes1 in adipogenesis is more
complicated than originally proposed.
First, the expression of Hes1 is not sensitive to the activity of Notch during
adipogenesis. Indeed, Notch is not the only regulator of Hes1 since it has been reported
that the transcription of hes1 is also regulated by the Stat3-Socs3 complex, as well as
Hedgehog and Wnt signaling pathways (Kageyama, Ohtsuka, & Kobayashi, 2008; Rani,
Greenlaw, Smith, & Galustian, 2016). More importantly, Hes1 also represses its own
transcription to maintain a relatively consistent level of expression (Hirata et al., 2002).
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Therefore, in early differentiation, the transcription of hes1 remains at the basal level
until a strong signal appears later in the differentiation process to drive enhanced
expression (Scroyen, Bauters, Vranckx, & Lijnen, 2015). As a consequence, neither the
treatment of DAPT nor a knockdown of Notch3 further reduces the expression of Hes1,
and in fact, the overexpression of Notch4 appears capable of elevating Hes1 expression
(Lai et al., 2013; Scroyen et al., 2015).
Besides the weak response of Hes1 to the Notch signaling pathway during
adipogenesis, the negative correlation between Hes1 and PPAR was not consistently
reported. Although Herzig et al. demonstrated that Hes1 suppressed adipogenesis by
blocking the transcription of ppar (Herzig et al., 2003), Ross and his colleagues found
that the expression of PPAR was decreased whether Hes1 was overexpressed or
knocked down in 3T3-L1 cells, suggesting dual roles of Hes1 in the expression of
PPAR during adipogenesis (Ross et al., 2004). Subsequent studies have also reported a
weak correlation between Hes1 and PPAR. For example, the overexpression of NICD4
was shown to increase the expression of both Hes1 and PPAR in 3T3-L1 preadipocytes
during in vitro adipogenesis (Lai et al., 2013). For in vivo studies, the Ad-NICD mouse
model with adipocyte-specific overexpression of NICD1 was established, and increases
in the expression of Hes1 in both inguinal WAT (iWAT) and epididymal WAT (eWAT)
were observed (Bi et al., 2016; Chartoumpekis et al., 2015). However, the transcription of
pparγ decreased in iWAT, but not eWAT (Chartoumpekis et al., 2015), while a random
variation in the protein level of PPARγ in eWAT of Ad-NICD mice was observed (Bi et
al., 2016). What is more interesting, is that compared to iWAT, eWAT was more affected
by the overexpression of NICD1 because the mass of eWAT continued to decrease as
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mice aged until it almost disappeared in 3-month old Ad-NICD mice (Bi et al., 2016;
Chartoumpekis et al., 2015). Therefore, it seems that Hes1 is not the only path for Notch1
to regulate the expression of PPAR in mature adipocyte lipid regulation.
Indeed, the final transcription suppressive effect on pparγ not only depends on the
expression but also the activity of Hes1. Hes1 binds and suppresses the transcription of
target genes after dimerization, a process known as active suppression. Again, Hes1
blocks the transcription of pparγ at the E-box in the promoter region (Herzig et al., 2003).
However, different from other basic helix-loop-helix (bHLH) transcriptional repressors,
Hes1 has higher preference for the N-box rather than the E-box motif (Sasai et al., 1992),
suggesting that the inhibitory effect of Hes1 on pparγ is not as high as that of other
targets containing N-boxes. Since the transcription of pparγ is regulated by multiple
cascades, the preferential inhibition of these targets may result in the final increase of
pparγ. On the other hand, different patterns of dimerization also determine the affinity of
Hes1 for target sequences. For instance, the heterodimer of Hes1 and Hey1 exhibits a
higher affinity for target sequences than the homodimer of Hes1 itself (Iso et al., 2001).
Therefore, the effect of Hes1 active repression on pparγ remains unclear. On other hand,
Hes1 is capable of indirectly inhibiting the transcription of genes with E-boxes by
competing for activator‐type bHLH factors such as E47, a process referred to as passive
repression (Kageyama et al., 2008). However, whether the passive repression is involved
in the regulation of PPAR has not yet been reported. In conclusion, both expression and
activity of Hes1 are highly dynamic during adipogenesis, and more in-depth studies are
required to fully discover the role and importance of Hes1 in the regulation of Notch
activity and PPAR expression.
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Hey1 and adipogenesis
Hey1 is another canonical Notch target that has been studied in adipogenesis.
Different from Hes1, the expression of Hey1 constantly increases as adipogenesis
progresses (Scroyen et al., 2015). It has been reported that the transcription of hey1 can
be directly activated by the BMP9-SMAD1/5 cascade (Wöltje, Jabs, & Fischer, 2015),
and the activation of TGF-β-SMAD3/4 cascade also transiently activates the transcription
of hey1 in a Notch-inhibited condition (Zavadil, Cermak, Soto-Nieves, & Böttinger,
2004). On the contrary, as a target of the Wnt/-catenin signaling pathway, COUP
transcription factor 2 (COUP-TFⅡ) blocks the transcription of ppar while also
suppressing the transcription of hey1 (Scroyen et al., 2015). Therefore, after the initiation
of adipogenesis, the activation of the BMP cascade and the down-regulation of COUPTFⅡ simultaneously lead to the increase in the transcription of hey1 (Scroyen et al.,
2015). However, Hey1 was positively correlated with the transcription of ppar, and no
further data has indicated the mechanism behind this observation. Therefore, Hey1 is
another target that may explain the inhibition of Notch during adipogenesis.

1.4.3

Non-canonical regulation of Notch to adipogenesis

Notch receptors and PPAR
The inhibitory role of Notch in adipogenesis was mostly determined by altering
the activity of Notch receptors. As upstream molecules of the Hes and Hey families of
transcription factors, Notch receptors may regulate the expression of PPAR through
other pathways. In other words, investigating the role of non-canonical Notch pathways
may be the key to answering more detailed and fundamental questions of how Notch
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signaling regulates cell behavior. Although there is no detailed mechanism yet reported,
Nueda et al. compared the effects of different Notch receptors in 3T3-L1 preadipocytes
on PPAR during adipogenesis. They observed an increase in the transcription of
ppar with the overexpression of full-length Notch1 but a decrease in ppar transcription
when any of the other three Notch receptors were overexpressed, suggesting that Notch1
might promote the expression of PPAR while other Notch receptors inhibit this
expression (Nueda et al., 2018). To date, there is no literature on the role of Notch2
during adipogenesis and limited research on Notch4 indicating a need for additional
research to uncover the mechanism through which each of the Notch receptors is
involved in adipogenesis.
Most of the research to date has focused on Notch1, where several in vitro studies
suggest a positive correlation between Notch1 and PPAR in 3T3-L1 and C3H10T1/2
cells during adipogenesis (Garcés et al., 1997; Nueda et al., 2018; Song et al.,
2016) However, since only transcription data of pparγ was reported in those studies, it is
difficult to determine whether changes in Notch1 are capable of affecting PPAR at the
protein level. Similar outcomes have also been observed through in vivo studies. Two
similar Adipoq-Cre/RosaN1ICD (Ad-NICD) mouse models were established to have
adipocyte-specific overexpression of NICD1. However, a random variation in the
expression of PPAR was shown in the WAT from different individual mice (Bi et al.,
2016; Chartoumpekis et al., 2015). Given the minimal amount of data and some
contradictory findings through in vivo studies, the relationship between Notch1 and
PPAR expression remain inconclusive.
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However, more has been learned through the use of in vitro studies where Notch1
appears to promote lipid accumulation during adipogenesis, while the adipoq-Cre
induced overexpression of NICD1 caused lipodystrophy and dedifferentiation in AdNICD mice (Bi et al., 2016; Chartoumpekis et al., 2015; Garcés et al., 1997). To answer
this, Bi and his colleagues further reported that the dimerization of PPAR and its ligand
was obstructed in NICD1-overexpressed WAT (Bi et al., 2016). However, given that
adiponectin is one of adipokines secreted by mature WAT, the overexpression of NICD1
driven by adipoq (the gene encoding adiponectin) only happens after late adipogenesis.
In brief, the function of Notch1 is not fully exerted throughout the process of fat tissue
differentiation. Moreover, since the overexpression of NICD1 further induced insulin
resistance in Ad-NICD mice, it is difficult to determine whether the obstructed activation
of PPAR is the endogenous cause of lipodystrophy or just a consequence of an insulin
resistance-induced decrease in energy metabolism. Therefore, the correlation between
Notch1 and PPAR activity during in vitro adipogenesis requires more research to
confirm.
Given that C/EBP and PPAR activate the transcription of each other during
adipogenesis, the varied activity of PPAR may cause a change of its own transcription.
On the other hand, since the free long-chain fatty acids (LCFAs) are endogenous ligands
of PPARs, both expression and activity of PPAR may be affected by the variation of
lipid storage during adipogenesis (Nakamura, Yudell, & Loor, 2014). Therefore, it is
worth further investigation to discover the relationship between Notch receptors and
other adipogenesis related molecules as Notch may also determine the final expression of
PPAR through the regulation of lipid accumulation.
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Notch1 and Srebp-1c
The sterol regulatory element-binding protein 1c (Srebp-1c) is one of the early
adipogenic markers and is the key transcription factor promoting de novo lipogenesis in
fat, liver, and muscle. The transcription of srebp-1c is activated by mTORC/STAT3
cascade and that mTORC/Srebp-1c cascade has been accepted as a critical metabolic
regulator promoting de novo lipogenesis (Ameer, Scandiuzzi, Hasnain, Kalbacher, &
Zaidi, 2014; Li, Brown, & Goldstein, 2010). As the substrate of the insulin/Akt pathway,
the activity of mTORC1 is highly sensitive to diet and nutrition (Hay & Sonenberg,
2004). It has been reported that NICD1 localized to the mitochondria activates the
mTORC2/Akt pathway in glioma neural stem cells and triple negative breast cancer cells
(Hossain et al., 2018; Lee et al., 2013), suggesting the possibility that Notch1 activates
the Akt/mTORC1 cascade in an insulin-independent manner. Indeed, it was also reported
that liver-specific deletion of Notch1 reduced the stability of mTORC1. On the contrary,
the activation of Notch1 caused an increased activity of mTORC1 in fatty liver,
suggesting Notch1 promotes lipogenesis by stabilizing mTORC1 (Pajvani et al., 2013).
More importantly, since notch1 is also the transcription target of STAT3, the Notch1
mediated activation of mTORC1 further elevates the level of Notch1 itself through
STAT3. Therefore, different from the other three Notch receptors, Notch1 is the only
receptor that is abundantly expressed in the late stage of fat differentiation (Lai et al.,
2013), and this positive feedback loop further promotes the positive regulation of Notch1
on Srebp-1c. In conclusion, the regulatory impact of Notch1 in mature fat may be much
greater than other Notch receptors.
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Notch Receptors and FABP4
Fatty acid binding protein 4 (FABP4) is highly expressed in adipocytes and assists
fatty acid transportation to increase lipid accumulation so that the expression of FABP4 is
often used as a late adipogenic marker in adipogenesis (Koppen & Kalkhoven, 2010).
FABP4 is frequently studied as a transcriptional target of PPAR A recent study has
determined that Notch also activated transcription of fabp4 by activating CSL complex in
a FoxO1-independent manner (Harjes et al., 2014). Subsequent studies further
determined that CSL-mediated activation of fabp4 was PPARγ independent (Jabs et al.,
2018). Therefore, the transcriptional activation of fabp4 mediated by PPARγ or Notch is
two independent events so that any increase in the level of PPARγ or NICDs appears to
increase the level of FABP4. Indeed, the transfection of any full-length Notch receptors
increased the transcription of fabp4 in 3T3-L1 cells, while the transcription of pparγ only
increased in the Notch1-overexpressed group and significantly decreased with the
overexpression of other three receptors (Nueda et al., 2018). Also interesting is that,
although the overexpression of Notch1 promoted the transcription of both pparγ and
fabp4, the fold increase of fabp4 was not as high as it was following the overexpression
of other three Notch receptors. As mentioned before, LCFAs is positively correlated to
the expression of PPARγ. However, as a lipid transporter, FABP4 has a much higher
affinity for LCFAs over PPARγ. Most of LCFAs are esterified in cells, so there is not
much free LCFAs for the activation of PPARγ and FABP4 (Nakamura et al., 2014). As a
consequence, the overexpression of FABP4 directly hinders the expression and activity of
PPARγ by competing with LCFAs. Therefore, the decrease of PPARγ in Notch2-4
overexpression samples may be partly due to the excessive activation of FABP4.
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Notch receptors and Lipolysis
Lipid accumulation depends on the dynamic balance of lipogenesis and lipolysis.
The relationship between Notch and lipolysis-related molecules has not been well
defined, but there is still some evidence suggesting that Notch regulates lipid
accumulation via lipolysis. Forkhead box protein O1 (FoxO1) is an essential transcription
factor that regulates glycogenolysis and gluconeogenesis in the liver. The transcription
activity of FoxO1 depends on its phosphorylation status mediated by the insulin/Akt
pathway. In the case of insulin resistance, the activity of FoxO1 is raised to activate the
transcription of glucose-6-phosphase (G6pc), resulting in the accelerated release of
glucose from liver to blood (Pajvani et al., 2011). In addition, the binding site of RBPj,
a canonical co-factor for Notch signaling, was also found on the promoter region of g6pc.
Therefore, the liver-specific loss of both Notch1 and FoxO1 is capable of reducing the
glucose level by decreasing the transcription of g6pc in liver (Pajvani et al., 2011).
Similarly, the decrease in the transcription of g6pc was also observed in DAPT treated
human liver cancer cells (HepG2), indicating that the positive transcriptional role of
Notch1 in G6pc exists in both in vivo and in vitro cases (N. J. Song et al., 2016).
However, since subsequent research observed a remission of insulin resistance in Notch1
deficient antisense transgenic (NAS) mice (N. J. Song et al., 2016), and since elimination
of G6pc specifically in the liver was insufficient to lower blood glucose (Mutel et al.,
2011), G6pc appears to not be the only target of Notch1 in the regulation of insulin
resistance. Therefore, the transcription profile of NAS mice was analyzed, and the
increase in the transcription level of lipid oxidation markers such as PPARα, UCP2, and
Acot1 was detected, suggesting that besides the regulation of G2pc, Notch1 still
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suppresses lipid metabolism through multiple mechanisms (N. J. Song et al., 2016). To
further confirm this, NICD1 was overexpressed through the transfection of retroviral
plasmids in HepG2 cells, and the transcription of pparα, ucp2, cpt1 was relatively
reduced. Briefly, Notch1 appears to promote hepatic lipid accumulation by suppressing
lipid oxidation in the liver.

1.5

Research motivation and experimental goals

Research on Notch and adipogenesis has been going on for decades, but
conclusive evidence clarifying its role rarely appears. The main reasons include, but are
not limited to, the heterogeneity of Notch expression during adipogenic differentiation,
the different effects of Notch on adipogenesis at different stages, and distinct regulatory
effects of each Notch receptor in the regulation of adipogenesis. By modulating the
activation of Notch receptors, Notch is primarily defined as a negative regulator of
adipogenesis. However, individual receptor focused research has consistently reported
contradictions. Notch1 is by far the most studied of the four receptors. Some studies
suggested that Notch1 inhibited adipogenesis by activating Hes1, but more evidence
showed that Notch1 positively regulated adipogenesis through a non-canonical pathway.
These opposite statements for the role of Notch make it difficult to accurately define the
final regulatory effect of Notch1 during adipogenesis. More importantly, the study of
Notch1 obviously cannot explain the inhibitory effect of Notch on adipogenesis.
Therefore, it is necessary to shift the focus of research to other Notch receptors.
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In the remaining receptors, the role of Notch4 has also been initially reported, but
the effects described are still inconsistent across the literature. Notch2 is often considered
to behave similarly to Notch1 because of the similarity of their NICDs. Notch3 seems to
exist independently of these receptors as several studies have reported the unique
significance of Notch3 in diseases and other aspects of development and human health.
For example, Notch3 mutations directly lead to Cerebral autosomal-dominant
arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL), while other
receptors are not involved in this disease (Machuca-Parra et al., 2017). Therefore, we
believe that Notch3 in adipogenesis has high research value. In this dissertation, we will
initially reveal the inhibitory effect of Notch3 on adipogenesis and then explore how
Notch receptors coordinate with each other by comparing the expression profile and
localization of Notch3 and Notch1 during adipogenesis. We have contributed to the
understanding of the biological significance of Notch1 and Notch3 in different stages of
adipogenesis, which can lead to additional studies and identification of therapeutic targets
for the treatment of human disease.

NOTCH3 IS INVOLVED IN ADIPOGENESIS OF HUMAN
ADIPOSE-DERIVED STROMAL/STEM CELLS
Published: Sandel, D. A., Liu, M., Ogbonnaya, N., & Newman, J. J. (2018). Notch3
is involved in adipogenesis of human adipose-derived stromal/stem cells. Biochimie,
150, 31–36. https://doi.org/10.1016/j.biochi.2018.04.020

2.1

Introduction

Adipose-derived stromal/stem cells (ADSCs), are multipotent adult stem cells that
are able to self-renew and are able to differentiate into a limited number of cells of the
mesodermal lineage. The secretion profile, immunomodulation, self-renewal,
multipotency, and homing characteristics of ADSCs make them a useful tool in
regenerative medicine, organ repair, and cell-based therapies (Gimble et al., 2013;
Izadpanah et al., 2006; Zuk et al., 2001). Therefore, it is critical that we gain a better
understanding of the mechanisms that regulate ASC state.
Derived from lipoaspirates of individuals, adipose stem cells are attractive tools in
the clinic because they are easy to access and offer therapeutic potential in their
immunomodulatory and regenerative capabilities. For ADSCs to be qualified for patient
use they must be (a) expandable ex vivo with high proliferative potentials; (b) possess
multipotent capability; and (c) must be easy to harvest for autologous transplantation
(Strem et al., 2005). Because of the vast clinical potential for ADSCs and the role of
Notch signaling in development, our research aims to generate a deeper understanding of
26
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stem cell maintenance and differentiation for safer applications. In addition, the types of
studies presented here have the potential to uncover genetic mechanisms of disease,
including in the case of ADSCs, insight into obesity and diabetes.
The role of stem cells is to aid in the regeneration and repair of various tissues in
the body. Stem cells are retained in a niche in a balanced state of self-renewing
multipotency, primed to differentiate when appropriate signals are received (Adam et al.,
2015; Almalki & Agrawal, 2016; Boyer et al., 2005). Minor genetic mutations or
alterations in the cellular environment may lead to undesired proliferation or
differentiation resulting in health abnormalities including obesity or cancer. Changes in
transcription factor expression, signaling pathway activity, genetic mutations, or changes
in the epigenetic landscape all influence gene expression profiles (Newman & Young,
2010). Examples of this include early studies where the loss of OCT4 induced
spontaneous differentiation of embryonic stem cells (Loh et al., 2006), or the
overexpression of MYOD forced the differentiation of myoblasts to muscle cells (Wei &
Paterson, 2001). This delicate cell state requires intense regulation in order to maintain
the health of the individual and so continued investigation of mechanisms that regulate
cell state to maintain a stem cell niche and drive proper differentiation remains critical.
Notch signaling is a contact dependent signaling pathway that is conserved across
all metazoans with a cell-type dependent role in development, niche maintenance, and
differentiation. Notch is activated when a ligand from the signal sending cell makes
contact with the receptor from a neighboring cell. This contact triggers two successive
cleavages of the Notch receptor. The final cleaved product, referred to as the Notch
intracellular domain (NICD) is transported to the nucleus recruiting other cofactors to
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activate downstream genes, including the hes and hey family of genes (Andersson,
Sandberg, & Lendahl, 2011; Gharbiah, Nakamoto, Johnson, Lambert, & Nagy, 2014; E.
C. Lai, 2002; Miele, 2006; Shi & Stanley, 2006; M. M. Wang, 2011). In the absence of
active Notch signaling, target genes are bound by co-repressors, which are then replaced
by the NICD.
The downstream effect of Notch activation is context dependent as it has been
shown to be involved in different stages of development, including vascularization and
angiogenesis (Hirashima, 2009) and myogenesis (Koch, Lehal, & Radtke, 2013;
Kurpinski et al., 2010; Vasyutina, Lenhard, & Birchmeier, 2007). In adults, Notch
signaling has been implicated in the maintenance of stem cell niches and directed
differentiation towards specific lineages (Collesi, Zentilin, Sinagra, & Giacca, 2008;
Hilton et al., 2008; Kim et al., 2014; Tian et al., 2015; Vujovic et al., 2007; Woo et al.,
2009).
Multiple studies have shown that Notch signaling promotes the self-renewing
characteristics of adult stem cells, while inhibition impairs this characteristic (Hilton et
al., 2008; Moriyama et al., 2014; Tian et al., 2015; Vujovic et al., 2007). However, to
date the studies on Notch signaling rely heavily on small molecule inhibitors that are not
specific for a given receptor. Those studies that have investigated the role of Notch3
specifically have done so primarily in vascularized smooth muscle cells (Baeten & Lilly,
2015; Domenga et al., 2004). In addition, some recent studies have indicated a role for
Notch signaling in adipogenesis (Ba et al., 2012; Chartoumpekis et al., 2015; James,
2013; B. Q. Song et al., 2015) but to our knowledge, there is no study that has evaluated
the role of Notch3 specifically in ASC adipogenesis. Studies have shown that although
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the structure of the Notch paralogs are similar, each of the four receptors may have
distinct functions in different cell types (Shimizu et al., 2002).
Because the downstream effect of Notch signaling is context dependent and since
most studies to date have used general -secretase inhibitors, understanding the role of
specific Notch receptors in ADSCs is necessary for proper characterization and use of
this stem cell population in the clinic. Here we report a role for Notch3 in regulating
adipogenesis. Specifically, we demonstrate that a loss of Notch3 does not impact hADSC
proliferation, but does lead to an increase in adipogenic differentiation, suggesting a role
for Notch3 in properly directing hADSC differentiation.
2.2
2.2.1

Materials and Methods

hADSC Cell Culture
Human adipose stem cells (hADSCs) were obtained from LaCELL (Lot #412) at

passage 0. All experiments were performed using cells that had not been passaged more
than six times. Cells were maintained in complete culture media (CCM) containing MEM
a (Life Technologies, 12,561-049), 20% fetal bovine serum (Atlanta Biologicals,
S11550), penicillin streptomycin (Life Technologies, 15,140-122) and L-glutamine (Life
Technologies, 25,030-081). The cells were maintained in a humidified incubator at 37 ℃
with 5% CO2. Cells were stained using trypan blue to establish viability and counted
using a Countess II FL Automated Cell Counter (Thermo Fisher Scientific,
AMQAX1000). For experiments assessing proliferation, biological triplicates were
counted individually, and results were averaged to calculate significance using a t-test.
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2.2.2

Notch3 siRNA
To knockdown notch3，Notch3 small interfering RNA (siRNA) for notch3 was

used (NOTCH3 Silencer Select siRNA s9641, 4392420). A nonspecific scrambled
siRNA, Silencer® Select Negative Control No. 1 siRNA, (Thermo Fisher Scientific,
4390843) was used as a negative control. Cells were seeded at densities of 50,000
cells/well in a 6 well tissue culture treated plate and 100,000 cells in a 60mmtissue
culture treated plate. After ADSCs reached 50% confluency, cells were transfected with
10 nM of siRNA combined with Lipofectamine® RNAiMAX Transfection Reagent (Life
Technologies, 13778075) and optiMEM (Life Technologies, 31,985-062). After 24 h of
siRNA treatment, the media was replaced with either complete control media or
adipogenic differentiation media (LaCell AdipoQual™ Medium, LaADM-500).
2.2.3

Cell Viability Assay
A cell viability assay was performed using ReadyProbes® Cell Viability Imaging

Kit (Blue/Red) (Life Technologies, R37610) following the manufacturer's protocol.
Images were taken on the EVOS FL imaging system in three different areas for each
biological sample. Experiments were performed in biological triplicates. Images were
analyzed using ImageJ software. The counted nuclei of both dead and live cells were
averaged for each area in the image and the experiment was performed in biological
triplicate. Three images were taken for each experiment at different locations in the well
(top, middle, and bottom) with that number being averaged for each individual
experiment. Biological triplicates were then averaged, and a t-test was used to calculate
significance.
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2.2.4

AlamarBlue Assay
Cell proliferation was measured using an alamarBlue assay (Invitrogen,

DAL1025) following the manufacturer's protocol. 1500 cells were seeded in a 96 well
tissue culture treated plate containing 200 mL of complete control media. The cells were
allowed to attach overnight before being transfected with notch3 or negative control
siRNA. After 96 h, 20 mL of alamarBlue was added to each well. Fluorescence was read
at an excitation wavelength of 570 nm and an emission wavelength of 585 nm using the
BioTek Cytation 5 Take3 plate reader 1 h, 2 h, 3 h, 4 h, and 24 h after addition of the
reagent. The fluorescence was normalized to a blank well containing only alamarBlue
reagent and media. Experiments were performed in triplicate and results averaged.
2.2.5

Adipogenic Differentiation and Oil Red O Staining
For adipogenic differentiation, complete control media was replaced with

adipogenic differentiation media 24 h after siRNA transfection. AdipoQual adipogenic
media was purchased from LaCell. The specifics of media are proprietary, but the media
does contain ligands for the glucocorticoid and PPAR receptors, the insulin receptor,
and an agent designed to increase the intracellular level of cAMP. After 14 days in
differentiation media, with media changes taking place every 72 h, cells were fixed and
stained, or RNA and protein were collected for gene expression and protein analysis
respectively.
Before Oil Red O staining, half of cells in the 60mm dishes were scraped and
collected with 100 mL RIPA buffer (Santa Cruz, sc- 24948) as shown in Figure 2-3 A.
The concentration of protein was quantified with Bio-Rad Protein Assay Dye Reagent
Concentrate following manufacturer's protocol (Bio-Rad, 500-0006). The remaining
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attached cells were fixed in 10% formalin (Azer Scientific, NBF-4-G) for 15 min, washed
with PBS, and then stained with Oil Red O (VWR, 11,411-412) for 20 min. Images were
taken at 4x and 10x magnification using a Nikon Eclipse TS100 microscope. The Oil Red
O was eluted with 60% isopropanol. The concentration of Oil Red O was measured by
the absorbance of 540 nm light and normalized to the protein concentration previously
measured.
2.2.6

RNA Extraction, cDNA synthesis, and qRT-PCR
To collect RNA from cells, media was aspirated, and wells were rinsed with

sterile PBS. TRIzol (Life Technologies, 15596018) was added to the well following the
manufacturer's protocol for RNA extraction. 1 mg of RNA was used for cDNA and was
synthesized using qScript cDNA Supermix (Quanta Biosciences, 101,414-102) following
the manufacturer's protocol. qRT-PCR was performed using Power SYBR® Green PCR
Master Mix (Applied Biosystems, 4367659). All qRT-PCR reactions were performed in
technical triplicates. GAPDH was used for normalization of qRT-PCR results. All
primers are listed in Table 2-1.
Table 2-1: primer table for qRT-PCR
Gene Name

Forward sequence (5’ to 3’)

Forward sequence (5’ to 3’)

gapdh
notch3
srebp-1c
ppar
adiponectin
fabp4
plin2
lpl

CCCCACTTGATTTTGGAGGGA
CACCCTTACCTGACCCCATCC
CTCTTGAAGCCTTCCTGAG
GCTGTTATGGGTGAAACTCTG
TTCCATACCAGAGGGGCTCA
AAACTGGTGGTGGAATGCGT
GCTGAGCACATTGAGTCACG
GAGATTTCTCTGTATGGCACC

AGGGCTGCTTTTAACTCTGGT
TTCGGACCAGTCTGAGAGGGA
GCACTGACTCTTCCTTGAT
ATAAGGTGGAGATGCAGGTTC
GAGTCGTGGTTTCCTGGTCA
GCGAACTTCAGTCCAGGTCA
TGGTACACCTTGGATGTTGG
CTGCAAATGAGACACTTTCTC

Product
size (bps)
206
81
138
351
89
95
102
276
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2.2.7

Western Blot
Cells were rinsed with 1xPBS and collected on cell culture dishes using RIPA

buffer (Santa Cruz, sc-24948) containing phosphatase and protease inhibitors (ThermoFisher, 78,441). The collection was lysed for 30 min at 4 _C. Cell lysates were removed
from the dishes and centrifuged in order to isolate protein and remove any cellular debris.
Protein concentrations were measured using Bio-Rad Protein Assay Dye Reagent
Concentrate following manufacturer's protocol (Bio-Rad, 500-0006). Protein samples
were loaded in a 10e15% precast gradient polyacrylamide gel (Bio-Rad, 456e1084).
Proteins were transferred on a Trans-Blot Turbo Mini PVDF Transfer Pack (Bio-Rad,
1704156) using the Bio-Rad Trans-Blot Turbo Transfer System. The membrane was
probed with NOTCH3 rabbit polyclonal antibody (Cell Signaling, 2889s), PPAR mouse
monoclonal antibody (Santa Cruz, sc-7273), and GAPDH rabbit polyclonal antibody
(Abcam, ab9485) at 4 _C overnight and incubated with secondary antibody rabbit IgG
(Abcam, ab6721) or mouse IgG (Abcam, ab6789) for 1 h at room temperature. The
membrane was visualized with ECL (Bio-Rad, 170e5060).
2.3
2.3.1

Results

Notch3 does not Influence hADSC Proliferation
A defining property of stem cells is their ability to continuously proliferate in an

undifferentiated state. Therefore, we were initially interested in the role that Notch3
might play in this process. Notch3 levels were diminished through siRNA-mediated
transient transfections and efficiency of knockdown was evaluated using qRT-PCR and
western blot. Significant loss of Notch3 transcript (~70% reduction in transcript) and
protein was observed up to 96 h post transfection (Figure 2-1 A, B). AlamarBlue assays
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were conducted up to 24 h following a 96 h transfection to monitor changes in
metabolism and provide a more sensitive and quantitative measure of proliferative
activity (Figure 2-1 C). The results demonstrate no significant difference in proliferative
rate, suggesting that Notch3 is not necessary for the maintenance of hADSC self-renewal
activity. In order to assess viability following a loss of Notch3, a live-dead staining assay
was conducted 96 h after transfection. The results demonstrate no significant difference
in live or dead cell count based on a fluorescence assay (Figure 2-1 D), suggesting that
Notch3 does not have a significant role in cell viability. These results confirm that
Notch3 is not involved in cell viability or proliferation.
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Figure 2-1: Notch3 does not influence viability or cell proliferation of human
adipose-derived stem cells. A. siRNA knockdown of Notch3 was assessed by qRTPCR and B. western blot. qRT-PCR was performed in triplicate. Western blot shows
biological replicates confirming knockdown. C. Loss of NOTCH3 does not have a
significant effect on cell proliferation as determined using an AlamarBlue assay. (*P <
0.05, P value: 0.0442). Error bars denote SE of mean. N=6. qRT-PCR was performed
in triplicate. Western blot shows biological replicates confirming knockdown. D. Loss
of NOTCH3 does not affect cell viability 96 h after a transfection as shown by
viability stain. Live cells are stained with DAPI (P value: 0.835). Dead cells are
stained with RFP (P value: 0.42). Error bars denote SE of mean. N=3. Live and dead
cells were counted for stained samples showing no significant difference in the
number of cells counted for each category.

2.3.2

Notch3 Has a Role in Regulating Adipogenesis
As stem cells are poised between self-renewal and differentiation, we were

interested to see what role, if any, Notch3 played in regulating adipogenesis of hADSCs.
Given the ability to easily induce adipogenesis of adipose-derived stromal/stem cells and
the critical need to understand what controls this cell fate, we decided to measure the
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influence of Notch3 on this fundamental biological process. Initially, we looked at levels
of Notch3 during adipogenesis and found that levels of Notch3 steadily increase during
the first 14 days of adipogenesis, returning to lower levels 21 days after induction,
suggesting that Notch3 may have a significant role in the regulation of early adipogenesis
(Figure 2-2 A). In order to confirm this was also true at the protein level and to ensure
the transient transfection would work for the length of the designed experiments,
knockdown was validated with a western blot 11 days after transfection and induction of
adipogenesis. An increase in Notch3 protein expression 11 days into differentiation was
observed, corresponding to the qRT-PCR data, and significant knockdown of Notch3 11
days after a single siRNA transfection confirmed the ability of the transient knockdown
to persist long enough for proper analysis of differentiation (Figure 2-2 B).

Figure 2-2: The transcription of notch3 increases in early adipogenesis. A. Notch3
transcript levels increase over time up to 14 days after adipogenic induction and then
return to levels close to that observed in undifferentiated hASCs by 21 days after
induction of adipogenesis. Statistical analysis comparing Notch3 expression during
differentiation to the undifferentiated control. *P< 0.05, **P<0.01, N=3. B. Protein
analysis confirms an increase in Notch3 expression 11 days after induction of
adipogenesis compared to undifferentiated cells and also demonstrates efficiency of
knockdown with a single transient transfection up to 11 days.

37

To determine the role of Notch3 in adipogenesis, cells were stained using Oil Red
O to monitor formation of lipid vesicles and RNA was collected to measure expression of
adipogenic gene markers. Morphology, imaging, quantification of Oil Red O staining,
and expression of PPAR, along with ppar and srebp1c transcript, confirm an increase
in adipogenesis following the loss of Notch3 (Figure 2-3 A, B, and C). These results
were further confirmed by analyzing transcript levels of adipogenic gene markers 7 days
after knockdown and induction of adipogenesis. A significant increase in expression of
adiponectin, fabp4, and plin2, with a similar trend observed for lpl further supporting the
increase in adipogenesis following the loss of Notch3 (Figure 2-3 D). By tracking
differentiation in the absence of Notch3, we conclude that Notch3 is involved in the
regulation adipogenesis and speculate that it may have a role in inhibiting adipogenesis
under standard culture conditions.
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Figure 2-3: Loss of Notch3 leads to increased adipogenesis. A. Oil Red O staining
indicates an increase in lipid vesicle formation. This is shown by images of stained
plates (left), microscopic images (middle), and quantification of stain normalized to
total protein present in control and knockdown conditions. *P< 0.05. N=3. B. Protein
analysis confirms knockdown of Notch3 in cells undergoing adipogenesis after 14
days and validates increase in adipogenesis by showing an increase in PPARg protein
expression. C. qRT-PCR confirmed increased adipogenesis after 14 days of induction
with significant increases in transcript for pparg and srebp1c. D. Additional markers
of adipogenesis were tested and further confirmed the impact that loss of Notch3
increased adipogenesis seven days after the induction. *P< 0.05, **P< 0.01. N=3.
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2.4

Discussion

The delicate balance maintained by stem cells between a self-renewing and
differentiating cell state requires tight control of transcription where cells are primed to
respond to specific signaling cascades responsible for promoting and inhibiting paths of
differentiation. The results presented here help to clarify the role of Notch signaling in
adult stem cells by investigating a single receptor, rather than using a more general
pathway inhibitor. Here we show, using siRNA-mediated knockdown, that the loss of
Notch3 is not lethal to the cells and does not impact hADSC self-renewal, but does have
an impact on adipogenesis. Specifically, the loss of Notch3 leads to an increase in
adipogenesis suggesting that Notch3 functions to regulate this lineage commitment when
present at wildtype levels. Earlier literature using a g-secretase inhibitor of Notch
signaling indicates an increase in adipogenesis of mouse adipose-derived stem cells by
promotion of PPAR expression (Huang et al., 2010). Our study isolates Notch3 and
suggests that at least this receptor, on its own, may have a significant impact in regulating
a transcriptional profile to regulate adipogenesis.

2.5

Conclusion

Previous studies have shown a role for Notch signaling in adipogenesis, including
identification of Notch1 in the regulation of metabolism and the generation of brown
adipose tissue (Bi & Kuang, 2015; Bi et al., 2014). By linking a second Notch receptor to
the regulation of adipogenesis, we have identified another potential target for the
treatment of obesity. Specifically, the mis-regulation of Notch3 activity could lead to
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accelerated conversion of ADSCs into adipocytes, offering a potential explanation for
uncontrollable weight gain and a novel genetic marker for obesity. In addition, these
findings help to identify pathways that can be examined and targeted in individuals to
anticipate potential side effects of stem cell transplants. With this data, we propose a
model where Notch3 may inhibit adipogenesis in ADSCs, helping to maintain a proper
balance of adipose stem cell state. In the absence of Notch3, gene expression is altered,
and proper breaks are lost, leading to an increase in adipogenesis compared to cells with
normal levels of Notch3. Additional research will be necessary to determine the role of
each of the other three Notch receptors, overlap in function, and compensatory roles in
the case of a receptor mutation in each of these developmental cascades in order to better
understand and utilize stem cells.

DISTINCT ROLES OF NOTCH1 AND NOTCH3 IN HUMAN
ADIPOSE-DERIVED STROMAL/STEM CELL ADIPOGENESIS
Under Review: Liu M, Logan H, Newman J.J. (2020). Distinct Roles of Notch1
and Notch3 in human adipose-derived stromal/stem cell adipogenesis. Stem Cell
Reviews and Reports.

3.1

Introduction

Obesity and obesity-related diseases are an ever-growing health concern. The
symptoms associated with obesity are in part related to the formation and accumulation
of adipose tissue that leads to inflammation and alters metabolism (Ghaben & Scherer,
2019). In order to better understand how obesity contributes to compounding health
concerns and identify potential therapeutic targets to curb these downstream affects, there
must be further investigation of the mechanistic process that drives and regulates
adipogenesis.
The increase in adipocytes in adults depends on the rate and regulation of
adipogenesis of both precursors and human adipose-derived stem/stromal cells
(hADSCs). hADSCs are a type of mesenchymal stem cell with the ability to self-renew
and differentiate into multiple types of cells from the mesoderm germ layer (Si et al.,
2019). Continuous research has shown that in a specific in vitro environment, hADSCs
can overcome the natural barriers of their multipotency and differentiate into nonmesodermal cell types suggesting that hADSCs can be a powerful tool in tissue
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regeneration (Radtke, Schmitz, Spies, Kocsis, & Vogt, 2009; Timper et al., 2006). In
addition, it has been observed that hADSCs display low antigenicity and strong
immunosuppressive effects leading them to receive extensive attention as a potential cellbased therapeutic (Traktuev, Parfenova, Tkachuk, & March, 2006). Despite the
tremendous potential, the clinical use of hADSCs has been limited due to the lack of
knowledge surrounding the molecular mechanisms that regulate and determine cellular
properties and behavior.
Several factors contribute to the properties and cell fate determination of
hADSCs, including the physical environment and endogenous signaling cascades that
lead to downstream changes in gene expression profiles. Notch signaling is a critical
contact-dependent developmental signaling pathway that is involved in cell fate
determination and human development. In addition, Notch has been implicated in
differentiation, proliferation, metabolism, and tumorigenesis (Giuli, Giuliani, Screpanti,
Bellavia, & Checquolo, 2019; Hossain et al., 2018; Meurette & Mehlen, 2018; Osathanon
et al., 2012). Indeed, the Notch pathway has also been largely accepted as a negative
regulator of adipogenesis in both in vivo and in vitro based studies that use γ-secretase
inhibitors to inhibit pathway activity (Huang et al., 2010; Osathanon et al., 2012; B. Q.
Song et al., 2015; Vujovic et al., 2007). However, when studies are performed to identify
the function of individual Notch receptors during adipogenesis, the role of the Notch
signaling pathway becomes less clear. In in vivo studies, the forced overexpression of the
Notch1 intracellular domain (NICD1) leads to lipodystrophy or dedifferentiation in
various transgenic mouse models (Bi et al., 2016; Chartoumpekis et al., 2015). However,
Notch1 deficient antisense transgenic mice exhibit higher lipid oxidation and less hepatic
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lipid accumulation when fed a high fat diet (N. J. Song et al., 2016). Similar
contradictions are also observed in in vitro studies. For example, an siRNA-mediated
Notch1 knockdown significantly reduces the expression of PPARγ in 3T3-L1 and
C3H10T1/2 cells (N. J. Song et al., 2016), and the overexpression of full-length Notch1
is capable of increasing the transcription of PPARγ in 3T3-L1 cells (Nueda et al., 2018).
In contrast, Notch1 appears to play a negative role in adipogenesis in Rosiglitazoneinduced thymic stromal cells (Y. Wang et al., 2018). Taken together then, the stable
inhibitory effect of Notch on adipocyte differentiation is complicated and cannot be fully
attributed to Notch1. Indeed, the role of the Notch pathway during adipogenesis also
relies on the other three receptors. To better understand how these four receptors work
independently, we previously reported that the knockdown of Notch3 increases
adipogenesis in hADSCs (Sandel et al., 2018). These finding were confirmed by studies
performed by Nueda et al. that demonstrated a decrease in the transcription of PPARγ in
3T3-L1 cells transfected with full-length Notch3 (Nueda et al., 2018). Despite these
findings, the mechanism for how Notch signaling regulates cell fate during adipogenesis
remains unclear.
With this study we sought to determine the relationship between Notch1 and
Notch3 to clarify ambiguity in the literature and have a better understanding for how the
Notch pathway regulates adipogenic differentiation of hADSCs. We observed high levels
of Notch3 in un-differentiated hADSCs where it appears to function as a suppressor of
adipogenesis, while the expression of Notch1 rose dramatically following the visible
formation of lipid vesicles. In addition, unlike Notch3, Notch1 was absent from the
nucleus during early adipogenic differentiation subsequently indicating disruption of the
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canonical Notch1 cascade. Furthermore, we found that Notch3 was capable of
suppressing adipogenesis in a Hes1/Hey1-independent manner and instead may maintain
the stem cell state of hADSCs by activating the canonical Wnt/β-catenin signaling
pathway during early adipogenesis. Together these observations provide new insights
into the role of specific Notch receptors during adipogenesis and introduce mechanisms
of crosstalk between signaling pathways, creating the possibility for novel therapeutic
targets in the fight against obesity and metabolic-related disease.

3.2
3.2.1

Materials and Methods

Cell Culture
Human ADSCs (AA20181218, P0) purchased from Obatala, Inc. Cells were

cultured in MEM-α (12571048, Thermo Fisher Scientific) supplemented with 1%
Pen/Strep (15140122, Thermo Fisher Scientific), 1% L-Glutamine (25030081, Thermo
Fisher Scientific), and 16% fetal bovine serum (s11550, Atlanta Biologicals) at 37℃ and
5% CO2 until 70-80% confluent. Cells were then detached using 0.25% Trypsin
(25200056, Thermo Fisher Scientific) and seeded onto tissue culture dishes (10 cm for
protein assays, 6-well for RNA assays, and 24-well for cell morphology assays) at the
same cell density of 1,667 cells/cm2. Media was replaced every 48 hours. All experiments
were performed with cells that had been passaged no more than three times to ensure
maintenance of stem cell properties.
3.2.2

Knockdown Studies
At 50% confluency, cells were transfected with scrambled (AM4611, Thermo

Fisher Scientific), Notch1- (s453558, Thermo Fisher Scientific), Notch3- (s9641, Thermo
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Fisher Scientific), RBP-Jκ- (s223923, Thermo Fisher Scientific), or β-catenin-specific
siRNA (s146154, Thermo Fisher Scientific) using RNAi Max Lipofectamine (13778075,
Thermo Fisher Scientific) and Opti-MEM (31985062, Thermo Fisher Scientific)
following manufacturer’s protocol. Specifically, when double-knockdowns were
performed in the experimental group, the same concentration of scrambled siRNA was
added in the single target knockdown group to ensure the same concentration of
transfected siRNA, and at the same time, the amount of RNAi Max Lipofectamine was
doubled accordingly to ensure the consistency among groups. Cells were then incubated
at 37℃ and 5% CO2 for 24 hours before the induction of adipogenesis using AdipoQual
adipogenic induction media purchased from Obatala Sciences, Inc. Media was changed
every 72 hours.

3.2.3

RNA Isolation and qRT-PCR
Total RNA was collected with TRIzol Reagent (15596018, Thermo Fisher

Scientific) and subsequently extracted with chloroform following the manufacturer’s
protocol. The concentration of RNA was quantified based on the absorbance at 260 nm
and cDNA was synthesized using 1000ng of RNA and qScript cDNA SuperMix
(101414106, Quantabio). PowerUp SYBR Green Master Mix (A25742, Thermo Fisher
Scientific) was used to perform qRT-PCR on a StepOnePlus real-time PCR system
(Thermo Fisher Scientific) following the manufacture’s protocol. Relative transcription
levels were normalized to GAPDH and fold change was calculated using the ΔΔCt
method. Primers were designed and optimized prior to use in qRT-PCR (Table 3-1). All
experiments were performed in biological triplicates with technical triplicates being run
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for each qRT-PCR reaction. The error bars represent standard error, and p-values were
calculated using a student t-test.
Table 3-1: Sequence of primers.
Gene
Name
gapdh
notch1
notch3
hey1
hes1
pparγ
ctnnb1

3.2.4

Forward sequence (5’ to 3’)

Forward sequence (5’ to 3’)

ACTAGGCGCTCACTGTTCTCT
CACGCTGACGGAGTACAAGT
CACCCTTACCTGACCCCATCC
TGAGCTGAGAAGGCTGGTAC
AAAAATTCCTCGTCCCCGGT
AGGATGCAAGGGTTTCTTCCG
ACAATGGCTACTCAAGGCTACC

CAATACGACCAAATCCGTTGACT
GGCACGATTTCCCTGACCA
TTCGGACCAGTCTGAGAGGGA
ATCCCAAACTCCGATAGTCC
GGCTTTGATGACTTTCTGTGCT
TGGGCGGTCATTATGAGACAT
GCTCCAGAAGCAGTCATCCA

Product
size (bps)
99
56
81
170
98
157
117

Protein Extraction and Western Blot
Total protein and nuclear protein were extracted with Pierce RIPA buffer (89900,

Thermo Fisher Scientific) and NE-PER Nuclear and Cytoplasmic Extraction Reagents
(78833, VWR), respectively. In both cases, Halt Protease & Phosphatase Inhibitor
Cocktail (78441, Thermo Fisher Scientific) was added to the buffer prior to treatment of
cells. Protein concentration was quantified using a BSA based Bradford assay (5000006,
Bio-Rad).
70 ng of total protein or 30 ng of nuclear protein was added to Laemmli Sample
Buffer (1610737, Bio-Rad) and boiled in a water bath for five minutes. Denatured
samples were loaded in a 4-15% Mini-PROTEAN TGX Gels (4561084, Bio-Rad) and
separated by electrophoresis before being transferred to a PVDF membrane (88518,
Thermo Fisher Scientific). The membrane was incubated with blocking buffer made up
of TBST (Tris Buffered Saline with 0.1% Tween 20) containing 5% w/v of non-fat milk
(9999s, Cell Signaling Technology), at room temperature for two hours. Target specific
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antibodies (Table 2) were added to the blocking buffer and membranes were incubated at
4℃ overnight. The probed membrane was washed with TBST three times and probed
with the corresponding secondary antibody (Table 3-2) and Precision Protein
StrepTactin-HRP Conjugate (1610308, Bio-Rad) at room temperature for one hour.
Membranes were washed with TBST three times and then covered with Clarity Western
ECL Substrate (1705060, Bio-Rad). Images was captured with the ChemiDoc Touch
Imaging System (Bio-Rad). The enrichment of each protein target was quantified using
ImageJ and normalized to GAPDH for total protein and TBP for nuclear protein.
Table 3-2: Antibodies for western blot
Name of Primary Antibodies
GAPDH
Notch1 (C-20)
Notch3
Hes1 (EPR4226)
Hey1
RBPSUH (RBP-Jκ)
Dlk (B-7)
Lamin B1 (A-11)
PPARγ (E-8)
PPARγ (C26H12)
TBP
GSK3β (27C10)
P-GSK3β (S9)
Non-P β-catenin (D13A1)

Catalog #
Ab9485
Sc-6014R
2889
Ab221788
Ab22641
5313
Sc-376755
Sc-377000
Sc-7273
2435
Ab125009
9315
5558
8814

Vendor
Abcam
Santa Cruz Biotechnology
Cell Signaling Technology
Abcam
Abcam
Cell Signaling Technology
Santa Cruz Biotechnology
Santa Cruz Biotechnology
Santa Cruz Biotechnology
Cell Signaling Technology
Abcam
Cell Signaling Technology
Cell Signaling Technology
Cell Signaling Technology

Secondary Antibodies
Goat Anti-Mouse IgG (HRP)
Goat Anti-Rabbit IgG (HRP)

Catalog #
Ab6789
Ab6721

abcam
abcam

3.2.5

Vendor

Concentration
1:3000
1:1000
1:1000
1:1000
1:1000
1:1000
1:1000
1:1000
1:1000
1:1000
1:1000
1:1000
1:1000
1:1000
Concentration
1:1000
1:1000

Co-Immunoprecipitation (Co-IP)
Co-immunoprecipitations were performed using the Pierce Crosslink Magnetic

IP/Co-IP Kit following the manufacturer’s protocol. Specifically, 2x106 cells were used
for each pull-down assay and Halt Protease & Phosphatase Inhibitor Cocktail (78441,
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Thermo Fisher Scientific) was used throughout protein purification and storage. To
isolate Notch3, the combination of anti-Notch3-2889 (Cell Signaling Technology) and
anti-Notch3-5276 (Cell Signaling Technology) was used; to pull down β-catenin, the
combination of anti- β-catenin (B-9) (Santa Cruz Biotechnology) and anti- β-catenin
(D10A8) (Cell Signaling Technology) was used (4 µl for each antibody). Normal Rabbit
IgG-2729 (Cell Signaling Technology) was used for the negative control pull-down
sample (Mock). To minimize the background and detection of antibodies, SDS reducing
sample buffer (39000, Thermo Fisher Scientific) was used for protein denaturation, and
1:1000 v/v of Mouse Anti-Rabbit IgG-HRP (5127s, Cell Signaling Technology) was used
as a secondary antibody for western blot.
3.2.6

Immunofluorescence Staining
Cells were fixed with 10% neutral buffered formalin for 20 minutes at 4℃ and

washed three times with PBS. Fixed cells were incubated with permeabilization buffer
(PBS with 0.2% Triton X-100) for five minutes and subsequently submerged with ImageiT FX Signal Enhancer (i36933, Thermo Fisher Scientific) for 45 minutes at room
temperature. After three washes with PBS, 1:100 v/v anti-Notch1 (Sc-6014R) or antiNotch3 (2889) was added to the blocking buffer (PBS supplied with 1% BSA, 0.05%
Tween 20, and 0.2% Triton X-100) and samples were incubated overnight at 4℃. Fixed
cells were washed three times with blocking buffer prior to the addition of secondary
Goat Anti-Rabbit IgG H&L Alexa Fluor 555 (ab150078, abcam), ActinGreen 488
ReadyProbes reagent (R37110, Thermo Fisher Scientific), and DAPI (62248, Thermo
Fisher Scientific) for the detection of target proteins, phalloidin, and cell nuclei,

49
respectively. After one hour at 4℃, cells were washed twice with blocking buffer and
once more with PBS prior to imaging with an EVOS Fluorescence Microscope.

3.3
3.3.1

Results

Notch1 and Notch3 are Uniquely Expressed during Adipogenesis
It is generally accepted that signaling pathways have redundancy to prevent the

significant impact that changes to a single receptor may have on a cell. Given that the
Notch pathway has four receptors, we first wanted to determine if an individual receptor
had a unique role in adipogenesis. If the pathway were redundant, then the knockdown
of a single receptor would not cause a phenotypic change or impact the differentiation of
hADSCs. We initially monitored the expression of Notch1 and Notch3, two highly
characterized receptors of the Notch pathway, over a 21-day period of adipogenic
differentiation. Both mRNA and protein indicated that the level of Notch3 increased
rapidly in the first 72 hours of adipogenic differentiation and diminished quickly after
that, while the expression level of Notch1 did not increase until five days after the
induction of adipogenesis (Figure 3-1). This temporal regulation during differentiation
suggests that Notch1 and Notch3 have unique roles during different stages of
adipogenesis.
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Figure 3-1: Notch1 and Notch3 are differentially expressed during adipogenesis. (A)
The relative levels of expression for Notch1 and Notch3 were measured with qRTPCR in hADSCs cultured with adipogenic media for 21 days. N=3, *p< 0.05, **p<
0.01. (B) Activated forms of Notch1 (NICD1) and Notch3 (NICD3) were detected by
western blot using protein lysate collected at various time points from hADSCs
cultured in adipogenic media for 21 days. (C) Relative levels of NICD1 and NICD3
from the western blot quantified using ImageJ software and normalized to GAPDH.
Furthermore, we observed morphological changes during adipogenesis indicating
that lipid droplet formation begins four days after the induction adipogenic
differentiation. This corresponded with the observed decrease in Notch3 expression and
simultaneous increase in Notch1 expression. Therefore, we hypothesized that Notch1
and Notch3 are uniquely expressed in cells during different stages of differentiation. To
support this, we performed immunofluorescence (IF) which indicated that Notch1 was
highly expressed in cells that had synthesized lipid vesicles with the expression level of
Notch1 increasing as adipogenesis progresses (Figure 3-2 A, left). Notch3, however,
was exclusively expressed in those cells newly committed to adipogenic differentiation
and rapidly diminished as lipid droplet formation began (Figure 3-2 A, right). Therefore,
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we believe that the overall increase of Notch1 and the decrease of Notch3 over time may
be the result of increased differentiation of the overall cell population from multipotent
hADSCs to preadipocytes (Figure 3-2 D).

Figure 3-2: Notch1 and Notch3 are distinctly expressed in hADSCs at different
stages of differentiation. (A) The localization of Notch1 and Notch3 throughout
adipogenesis is shown with immunofluorescence of cells cultured for 5 or 14 days in
adipogenic media. DAPI was used to stain nuclei, and Phalloidin was used to stain Factin filaments. Lipid vesicles are indicated with yellow arrows. Scale bars indicate
200 µm. (B) The illustration represents a model for the expression profile of Notch1
and Notch3 during adipogenesis. Notch1 expression increases as the number of
differentiated hADSCs increases, whereas Notch3 expression diminishes over time as
more cells undergo adipogenesis and fewer cells remain in a multipotent cell state.
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3.3.2

Notch3 Plays a Dominant Role in Early Adipogenesis when Compared to

Notch1
To determine the potential role for Notch1 and Notch3 during adipogenesis,
hADSCs were transfected with siRNA targeting each receptor individually and in
combination. Following transfection of the siRNA, cells were induced to differentiate
with adipogenic media for six days, at which point RNA and protein were collected for
analysis. Both transcript and protein expression validated the knockdown of Notch3 and
indicated a significant increase in Notch1. Conversely, although the knockdown of
Notch1 was validated with a decrease in the levels of transcript and protein, it did not
affect the expression of Notch3 even after six days of adipogenic differentiation (Figure
3-3 A and B). Since the co-expression of Notch1 and Notch3 was not observed in cells
until nearly five days after the induction of adipogenesis, and even though it was brief
(Figure 3-2 A), we believe that Notch3 does not directly suppress the expression of
Notch1. The observed increase in Notch1 expression may instead be the result of an
increased number of differentiated hADSCs following the Notch3 knockdown, not a
direct effect of the Notch3 knockdown itself.
When examining adipogenesis of these samples, both mRNA and protein
confirmed an increase in the expression of PPARγ in the Notch3 knockdown samples,
whereas the stable decrease in the protein expression of PPARγ was not observed
following the knockdown of Notch1 (Figure 3-3 C and D). Finally, a double knockdown
was also performed, where both Notch1 and Notch3 siRNA were transfected
simultaneously into hADSCs. An increase in the expression of PPARγ in the double
knockdown was observed, although not to the extent observed following a Notch3 only
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knockdown (Figure 3-3 D). This data further confirms that Notch1 and Notch3 may
work independently to regulate adipogenesis, and that Notch3 may play a dominant role
in this process. Together with the expression profiles of Notch1 and Notch3, the data
suggests that Notch3 may be highly expressed in the early stages of adipogenesis to
maintain hADSCs in a self-renewing, primed stem cell state, while Notch1 is expressed
in later stages to regulate the accumulation of lipid droplets.
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Figure 3-3: Notch1 and Notch3 affect the expression of PPARγ differently during
adipogenesis. (A) The effects of the Notch1, Notch3, or Notch1-3 double knockdown
on the transcription of notch1 and notch3 were evaluated using qRT-PCR six days
after adipogenic differentiation of hADSCs. N=3, *p< 0.05, **p< 0.01. All data was
normalized to gapdh. (B) The effects of the knockdown of Notch1, Notch3, or
Notch1-3 on cleaved Notch1 and Notch3 were assessed by western blot six days after
inducing adipogenic differentiation of hADSCs. GAPDH was used as the loading
control for total protein lysate. (C) Relative changes of pparγ1/2 transcripts were
measured with qRT-PCR following the knockdown of Notch1, Notch3, or Notch1-3
double knockdown six days after inducing adipogenic differentiation of hADSCs.
N=3, *p< 0.05, **p< 0.01. Data was normalized to gapdh. (D) The change in PPARγ1
and 2 protein was assessed by western blot following the knockdown of Notch1,
Notch3, or the Notch1-3 double knockdown six days after inducing differentiation of
hADSCs. PPARγ1 is the lower band (50 kDa), and PPARγ2 (55 kDa) is the upper
band. Lamin B1 was used as the loading control for nuclear protein lysate. In all
figures, siCtrl indicates samples transfected with negative control siRNA; siN1 and
siN3 indicate those samples transfected with Notch1 and Notch3 specific siRNA,
respectively; and siN1+3 indicates those samples transfected simultaneously with both
the Notch1 and Notch3 specific siRNAs.
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3.3.3

Notch1 does not Localize to the Nucleus during Early Differentiation
Previous studies indicated that the overexpression of NICD1 suppresses the

expression of PPARγ in white adipose tissues (WAT) by activating the transcription of
hes1 (Chartoumpekis et al., 2015). However, a consistent change in the expression of
Hes1 or Hey1 was not observed in our experiments leading us to question the role of the
canonical Notch1 cascade during in vitro adipogenesis. To develop a better understanding
of the Notch1 and Notch3 cascades during adipogenesis, IF was performed to determine
Notch1 and Notch3 localization in hADSCs before and three days after adipogenic
induction (Day 0 and Day 3, respectively). The level of nuclear NICD1 was significantly
reduced 72 hours after inducing adipogenesis (Figure 3-4 A), whereas NICD3 was still
present in the nucleus at this early time point in adipogenic differentiation (Figure 3-4
B).
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Figure 3-4: Notch1 is absent from the nucleus during adipogenesis. (A)
Immunofluorescence was used to detect changes in Notch1 localization in hADSCs
72 hours after inducing adipogenesis. DAPI was used to stain nuclei. Scale bars
indicate 200 µm. (B) Immunofluorescence was used to detect Notch3 localization in
hADSCs  hours after inducing adipogenesis. DAPI was used to stain nuclei. Scale
bars indicate 200 µm.

To obtain a more global view of localization, nuclear protein was isolated at
various time points over a period of 21 days from cells cultured in adipogenic media.
Notch3 nuclear protein (NICD3), was observed to be highest during the initiation of
adipogenesis and diminished within the first five days. Notch1 nuclear protein (NICD1),
however, appeared to fluctuate more during adipogenesis, with expression decreasing and
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increasing over the three-week period (Figure 3-5 A). The levels of NICD1 and NICD3
in the nucleus were quantified with ImageJ, and the ratio of nuclear to total protein for
each receptor was calculated (Figure 3-5 B and C). The data showed that the ratio of
nuclear NICD3 remained relatively constant at all times. However, the relative amount of
nuclear NICD1 decreased dramatically at the start of adipogenic differentiation and did
not rebound until 21 days after the induction of differentiation (Figure 3-5 C). Together,
this data suggests that Notch1 is not active in the nucleus during adipogenesis, whereas
Notch3 is still a potential candidate to regulate adipogenesis in a canonical manner.

Figure 3-5: The nuclear localization of Notch1 is limited as adipogenic induction
initiates. (A) Expression of nuclear NICD1 and NICD3 in hADSCs cultured in
adipogenic media was determined at different time points using western blot. The
TATA-binding protein (TBP) was used as a loading control for nuclear protein. (B)
The protein level of NICD1 and NICD3 from Figure 3C was quantified using ImageJ
and the relative abundance of each band was normalized to TBP. (C) The relative
abundance of NICD1 and NICD3 was subsequently normalized to the relative level of
each NICD in the total protein lysate from Figure 3-1 B.
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3.3.4

The knockdown of Notch3 Promotes Early Adipogenesis of hADSC
We have previously demonstrated that the knockdown of Notch3 leads to

increased adipogenesis 14 days after adipogenic induction (Sandel et al., 2018). Given
the sensitive response of Notch3 to early adipogenic differentiation, mRNA and protein
of hADSCs were collected before the appearance of lipid drops. Within 72 hours of
inducing adipogenesis following the knockdown of Notch3, there was an increase in
transcript and expression of PPARγ1 and a decrease in the expression of Dlk1, a
preadipocyte marker (Figure 3-6 A and B). Unlike the increase in Notch1 expression
following the knockdown of Notch3 six days after inducing differentiation of hADSCs
(Figure 3-6 A and B), after only 72 hours, the level of transcription and the expression of
the active form of Notch1 decreased (Figure 3-6 C and D). In addition, there was no
observed change in hes1 expression, although there was an increase in hey1 transcript but
not protein. The overall absence of change in Hes1 and Hey1 protein levels suggests that
Hes1 and Hey1 may not be targets of Notch3 in early adipogenic regulation.
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Figure 3-6: The knockdown of Notch3 leads to increased adipogenesis independent
of Hes1/Hey1. (A) Changes of notch3 and pparγ1/2 transcript following the
knockdown of Notch3 in hADSCs 72 hours after inducing differentiation were
measured with qRT-PCR. All data was normalized to gapdh. N=3, *p< 0.05, **p<
0.01. (B) The protein level of Notch3, both full length (FL-Notch3) and cleaved
(NICD3), Dlk1, and PPARγ1 following the knockdown of Notch3 and 72-hour
induction of adipogenesis was determined by western blot. (C) The relative levels of
transcript for Notch signaling components following the knockdown of Notch3 was
measured with qRT-PCR 72 hours after adipogenic induction. Data was normalized to
gapdh. N=3, *p< 0.05. (D) The protein level of Notch1, both full length (FL-Notch1)
and cleaved (NICD1), Hes, and Hey1 following the knockdown of Notch3 and 72hour induction of adipogenesis was determined by western blot. In all figures, siCtrl
indicates samples transfected with negative control siRNA, and siN3 indicates those
samples transfected with Notch3 specific siRNA.
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3.3.5

Notch3 Suppresses Adipogenic Differentiation Through a Non-canonical

Pathway
Since PPARγ1 is expressed in multiple cell types, whereas PPARγ2 is exclusively
expressed in adipocytes, adipogenic differentiation was extended to six days in order to
obtain a better understanding of the relationship between Notch3 and PPARγ2. Similar to
hADSCs cultured for three days in adipogenic media, the expression of PPARγ1 and
PPARγ2 increased while the expression of Hes1 and Hey1 were unaffected by the
knockdown of Notch3 six days after adipogenic differentiation (Figure 3-7 A and B). To
further evaluate a role for the canonical Notch3 signaling cascade in the regulation of
adipogenesis, we performed an siRNA-mediated knockdown of the Notch co-factor RBPJκ. As Figure 3-7 C shows, the loss of RBP-Jκ caused a decrease in the expression of
Hey1 but had no effect on the expression of Hes1, suggesting that the Hey1 expression is
more sensitive to the presence of the CSL complex during adipogenesis. Surprisingly, the
expression of neither PPARγ1 nor PPARγ2 was affected, again raising the question as to
whether or not the canonical Notch pathway is a significant component in the regulation
of adipogenesis. Finally, we compared the downstream effect of the simultaneous
knockdown of both Notch3 and RBP-Jκ in hADSCs followed by six days of adipogenic
differentiation. The loss of Notch3 did not cause a further reduction in the expression of
Hes1 and Hey1 but did result in an increase in the expression of PPARγ (Figure 3-7 D
and E). Since PPARγ expression increased after the knockdown of Notch3 both in the
presence and absence of RBP-Jκ siRNA, we believe that Notch3 regulates adipogenesis
through a non-canonical pathway.
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Figure 3-7: Notch3 suppresses early adipogenesis in a Hes/Hey-independent manner.
(A) The change in expression of Notch-associated proteins and PPARγ1/2 after the
knockdown of Notch3 was determined using western blot six days after inducing
adipogenesis. (B) Changes in transcript levels of Notch pathway components and
pparγ following the knockdown of Notch3 were determined six days after inducing
adipogenic differentiation using qRT-PCR. All data was normalized to gapdh and
fold change was determined by comparing data from samples transfected with Notch3
specific siRNA to those transfected with negative control siRNA. N=3, *p< 0.05,
**p< 0.01. (C) The change in expression of Notch-associated proteins and PPARγ1/2
was determined by western blot following the knockdown of RBP-J and six days
after inducing adipogenesis. (D) The change of Notch-associated proteins and
PPARγ1/2 was determined by western blot following the knockdown of RBP-J and
double-knockdown of Notch3 and RBP-J and six days after the induction of
adipogenesis. (E) Changes in the transcript levels of Notch pathway components and
pparγ following the double-knockdown of Notch3 and RBP-J. All data were
normalized to gapdh and fold change was determined by comparing data from
samples transfected with Notch3 and RBP-J to those transfected with only the RBPJ specific siRNA. N=3, *p< 0.05, **p< 0.01. In all figures, siCtrl indicates samples
transfected with negative control siRNA, siN3 indicates those samples transfected
with Notch3 specific siRNA, siRBP-J indicates those samples transfected with RBPJ specific siRNA.
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3.3.6

Adipogenic Regulation by Notch1 and Notch3 is Associated with Wnt

Signaling
As Notch3 is expressed during early adipogenesis and the knockdown of
Notch3 leads to an increase in adipogenesis, it appears that Notch3 may be a critical
component of adipogenic commitment. Given that the canonical Wnt/β-catenin signaling
pathway has been demonstrated to also suppress adipogenesis (Tang & Lane, 2012), we
examined the level of GSK3β protein six days after inducing adipogenesis. The
knockdown of Notch1 did not appear to affect the level of inactive GSK3β but did
significantly reduce the level of total GSK3β protein expressed. On the other hand, the
level of inactive GSK3β remained unaffected following the Notch3 knockdown, while
the level of total GSK3β protein slightly increased following the knockdown of Notch3
(Figure 3-8 A). As it has been demonstrated that the Notch3 knockdown increases the
protein level of Notch1 (Figure 3-3 A and B), both Notch1 and Notch3 were
simultaneously knocked down. The decrease of GSK3β following the double knockdown
further suggests that Notch1 may be involved in regulating the expression or the stability
of GSK3β (Figure 3-8 A).
To determine if the variation of GSK3β eventually alters the activity of the
canonical Wnt signaling pathway, we measured the level of active β-catenin, the substrate
of GSK3β and terminal component of the canonical Wnt signaling pathway. The Notch1
knockdown decreased the level of total GSK3β (Figure 3-8 A), but it did not affect the
amount of active β-catenin in either the cytoplasm or nucleus (Figure 3-8 B).
Conversely, following the knockdown of Notch3, although the level of GSK3β increased
slightly, the level of active β-catenin in the cytoplasm was reduced. In addition, the
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decreased expression of GSK3β after the knockdown of Notch1 did not restore the level
of nuclear β-catenin protein to control levels in the Notch3 knockdown sample. Since the
change in active β-catenin protein may also result from the variation in the transcription
of ctnnb1 (the gene that encodes β-catenin), we performed qRT-PCR but did not observe
a change in the transcription of ctnnb1 following the knockdown of Notch3 and six days
of adipogenic differentiation (Figure 3-8 C). Collectively, this suggests that Notch3 may
have a role in regulating the stability of β-catenin with less of a role in the regulation of
GSK3β expression or activity.
Since the activity of β-catenin is highly involved in the adipogenic commitment
of cells, we shortened the period of investigation from six to four days after inducing
adipogenesis. The transcription level of β-catenin was not changed following the
knockdown of Notch3 (Figure 3-8 C), but a decrease in the level of active β-catenin in
the nucleus was observed (Figure 3-8 D). To better understand how the loss of Notch3
reduces the level of β-catenin, a Co-IP was performed and demonstrated an interaction
between Notch3 and β-catenin. This physical interaction suggests a possible explanation
for the protective effect we observed for Notch3 on β-catenin (Figure 3-8 E). However,
we did not observe Notch3 protein when we pulled down β-catenin. This may be due to
higher levels of β-catenin in these cells where only a small percentage of β-catenin
actually interacts with Notch3, thereby diluting the potential signal. To confirm the effect
that β-catenin and Notch3 have on adipogenesis, cells were transfected with β-catenin
and Notch3 specific siRNA, respectively. The decreased expression of Notch3 appeared
to have a similar effect on adipogenesis, as the β-catenin knockdown specifically resulted
in decreased β-catenin and increased PPARγ2 expression (Figure 3-8 D), suggesting the
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inhibitory effect of Notch3 on adipogenesis may be accomplished through an interaction
or relationship with nuclear β-catenin.

Figure 3-8: The loss of Notch1 and Notch3 differentially impacts Wnt signaling
during adipogenesis. (A) Changes in total and inactive GSK3β protein were
determined by western blot following the knockdown of Notch1, Notch3, or Notch1
& 3 double knockdown six days after adipogenic induction. (B) Changes in active βcatenin in the cytoplasm and nucleus were determined by western blot following the
knockdown of Notch1, Notch3, or Notch1 & 3 six days after inducing adipogenesis.
(C) The relative levels of CTNNB1 (the gene codes β-catenin) transcript were
determined by qRT-PCR following the knockdown of Notch3 knockdown in hADSCs
four and six days after inducing adipogenic differentiation. N=3, p> 0.05. (D)
Changes in active β-catenin and PPARγ1/2 in the cytoplasm and nucleus were
assessed by western blot following the knockdown of β-catenin or Notch3 four days
after inducing adipogenesis. (E) Notch3 and β-catenin were isolated using coimmunoprecipitation in the presence and absence of Notch3 siRNA three days after
inducing adipogenic differentiation. As described in the Methods section, Mock
indicates samples pulled down with negative control Rabbit IgG. In all figures, siCtrl
indicates samples transfected with negative control siRNA; siN1, siN3, and si-cat
indicate those samples transfected with Notch1, Notch3, and -catenin specific
siRNA, respectively; and siN1+3 indicates those samples transfected simultaneously
with both the Notch1 and Notch3 specific siRNAs.
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3.4

Discussion

Here we provide evidence for the distinct roles of Notch1 and Notch3 during
hADSC adipogenesis. Based on our data, we propose a mechanism for further
investigation where the Notch pathway regulates adipogenesis through a noncanonical
method and interaction with β-catenin (Figure 3-9). Specifically, we speculate that in
self-renewing hADSCs, the expression of both Notch1 and Notch3 is low in order to
maintain basic regulatory activity of these two receptors inside and outside the nucleus.
Following the initiation of adipogenesis, we observed that Notch3 was upregulated. Since
we found a direct interaction and a positive correlation between NICD3 and active βcatenin, we suspect that the increase in the level of NICD3 is associated with the
activation of the canonical Wnt signaling pathway that functions to suppress adipogenesis
(Tang & Lane, 2012). On the other hand, the expression of Notch1 did not increase and
its nuclear activity was low in un-differentiated hADSCs, suggesting that the function of
the canonical Notch1 cascade may be suppressed during early adipogenesis. As hADSCs
were directed towards an adipogenic lineage, Notch3 expression decreased, indicating
that Notch3 likely does not have a role in regulating lipid metabolism during late
adipogenesis. Notch1 was highly expressed in differentiated hADSCs, and the amount of
Notch1 increased as the number of cells undergoing adipogenic differentiation also
increased. However, the increased expression of Notch1 expression did not compensate
for the low ratio of NICD1 translocating to the nucleus throughout adipogenesis,
suggesting that cytoplasmic NICD1 may be a critical candidate in the regulation of lipid
accumulation. Based on this model, we believe that Notch3 is associated with the
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maintenance of stemness while Notch1 may be a factor that regulates the metabolism
associated with differentiated adipocytes.

Figure 3-9: Model of Notch1 and Notch3 function during adipogenesis. In selfrenewing hADSCs Notch1 and Notch3 are expressed and appear to regulate cell fate
in both the cytoplasm and nucleus (left). When cells are stimulated to begin
adipogenesis, Notch1 is no longer localized to the nucleus, while Notch3 is highly
expressed. This increased expression of Notch3 may be responsible for a physical
interaction that protects β-catenin from phosphorylation and degradation (right).
Image credit to Tom Futrell, School of Design, Louisiana Tech University.

The contradictions observed throughout the study of Notch signaling are often
explained by the differences in cell lines used for experimentation. Comparing our own
results with those trends observed in other cell lines we find that Notch3 was expressed
earlier than Notch1 in hADSCs during adipogenesis, similar to the published results
using 3T3-L1 preadipocytes (P.-Y. Lai et al., 2013). To confirm the role of Notch1 and
Notch3 in adipogenesis, target-specific siRNA was applied, again with similar effects on
the transcription of PPARγ as those observed for full-length Notch1/Notch3 transfected
3T3-L1 cells (Nueda et al., 2018). Together, our data suggests that Notch1 and Notch3
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behave similarly in both hADSCs and 3T3-L1 preadipocytes offering validation to the
use of hADSCs as a model for the study of adipogenesis.
Numerous studies indicate that Notch1 can activate the transcription of Notch3
via the CSL complex (Ohashi et al., 2010). In our study, the lower expression of Notch3
following the knockdown of RBP-Jκ was indeed observed; however, the downregulation
of Notch3 following the knockdown of Notch1 was not clearly exhibited. To answer that,
we performed IF of hADSC six days after inducing adipogenic differentiation and did not
observe the co-localization of Notch1 and Notch3 suggesting that the regulatory effect of
Notch1 on Notch3 might be minimal. Moreover, the absence of NICD1 from the nucleus
during adipogenesis further supports the implication that Notch1 does not directly
regulate the transcription and expression of Notch3. Instead, we observed an increase in
the expression of Notch1 after the knockdown of Notch3 six days into adipogenic
differentiation of hADSCs, aligning with publications reporting that the forced
overexpression of full-length Notch3 can reduce the transcription of Notch1 in 3T3-L1
preadipocytes (Nueda et al., 2018). As the early expression of Notch3 appears to suppress
adipogenesis, and the high expression of Notch1 only occurs after the formation of lipid
vesicles, the increased expression of Notch1 after the knockdown of Notch3 may be
caused by the increased number of differentiated hADSCs, not necessarily by a direct
relationship or interaction between Notch1 and Notch3.
Based on the sensitivity of the expression and stable inhibitory effect of Notch3
during adipogenesis, Notch3 appears to be a critical gatekeeper that maintains hADSCs
in a stem cell state during differentiation. Since the ratio of nuclear to total protein of
NICD3 is not affected by adipogenic induction, and the inhibitory effect of the Notch3
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knockdown on PPARγ2 is minimized with the transfection of RBP-Jκ specific siRNA,
we believe that Notch3 may regulate adipogenesis in both the nucleus and the cytoplasm.
Therefore, we attempted to investigate the role of Notch3 in regulating the expression of
Hes1 during adipogenesis, as pparγ has been reported to be a direct target of Hes1
(Herzig et al., 2003). However, the downregulation of Hes1 was not observed in cells that
were exposed to adipogenic media for either three or six days following the knockdown
of Notch3. Moreover, the knockdown of RBP-Jκ did not diminish the expression of Hes1,
suggesting the expression of Hes1 may be independent of the Notch pathway. Indeed, the
Notch-independent activation of Hes1 has been observed in the study of neuroepithelial
cells (Hatakeyama et al., 2004) and it has been reported that the activated Stat3-Socs3
complex directly induces the transcription of hes1, suggesting that the role of NICDs in
controlling Hes1 expression during adipogenesis requires further investigation
(Kageyama et al., 2008). In addition, Hes1 appears to participate in an autoregulatory
loop whereby it acts to repress its own transcription, further supporting the idea that the
regulation of Hes1 exists beyond the canonical Notch signaling pathway (Hirata et al.,
2002). On the other hand, the transcription of hey1 appeared to be sensitive to the
diminished expression of RBP-Jκ but not Notch3, suggesting that other receptors might
be present and signaling through RBP-J to compensate for the decreased expression of
Notch3. In addition, as the transcription of hey1 can be directly activated by BMP9SMAD1/5 or TGF-β-SMAD3/4 cascades in a Notch-independent manner (Wöltje et al.,
2015; Zavadil et al., 2004), it is likely that there is significant interaction and cross-talk
between all of these pathways and the regulation of gene families.
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Finally, since the loss of RBP-Jκ did not increase PPARγ expression, as was
observed following the knockdown of Notch3, we believe that cytoplasmic NICD3 may
have a negative role in the expression of PPARγ. Here we show that this is at least partly
true when considering the interaction of Notch and Wnt signaling. Coimmunoprecipitation indicated a physical interaction between Notch3 and β-catenin, and
the knockdown of Notch3 reduced the protein expression but not transcription of βcatenin both four and six days after initiating adipogenic differentiation of hADSCs,
suggesting that Notch3 may play a role in protecting β-catenin from degradation.
However, the decrease in nuclear β-catenin was only observed four days after inducing
adipogenesis, which may be the result of varied nuclear translocation of β-catenin during
different stages of adipogenesis. Together our data suggests that Notch3 is a negative
regulator of adipogenesis through a non-canonical path and indicates a need for further
investigation to determine the specific mechanisms through which the Notch signaling
pathway interacts with other signaling pathways to direct cell fate.

CONCLUSION AND FUTURE DIRECTIONS

4.1

Conclusion

Adipogenesis has been recognized as a critical property of stem cells in the
regulation of metabolism. To expose the key factors that determine the fate of stem cells,
the Notch signaling pathway has been the target of a significant number of studies for its
role in stem cell homeostasis and directed differentiation. Despite decades of
investigation, the role of Notch in adipogenesis has not yet been fully revealed. In this
dissertation, we studied and compared the distinct roles of Notch1 and Notch3 in hADSC
adipogenesis to reveal greater insight into the role of these receptors and method in which
Notch regulates cell fate.
We initially began our studies with Notch3 because of the higher level of
expression of the receptor in self-renewing hADSCs and the limited literature on its
unique role in adipogenesis. The loss of Notch3 mediated by target specific siRNA
resulted in increased adipogenesis 14 days after adipogenic induction, which was
represented by an increased number of lipid vesicles and increased expression of
adipogenic markers. Therefore, we hypothesized that Notch3 could be the key receptor
suppressing adipogenesis. To further clarify which adipogenic stage is suppressed by
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Notch3, we examined the expression profile of Notch3 and observed the expression of
Notch3 during early adipogenesis. Specifically, we investigated the effect of the Notch3
knockdown three and six days after inducing adipogenic differentiation of hADSCs to
determine the role of Notch3 during early adipogenesis. As expected, all induced
hADSCs exhibited increased adipogenesis after the knockdown of Notch3. However, we
did not observe a change in the expression of canonical Notch targets leading us to think
that Notch3 may be acting in the cytoplasm to regulate cell fate rather than directly
controlling target gene expression. Since -catenin has been characterized as a key
regulator that prohibits stem cells from preadipocyte commitment, we attempted to
identify a relationship between Notch3 and -catenin. Indeed, we performed Co-IPs and
observed a direct protein-protein interaction between Notch3 and -catenin. In addition,
the knockdown of Notch3 led to a decrease in the level of active -catenin. Therefore, we
believe that the regulation of -catenin is one path regulated by Notch3 during
adipogenesis.
The progress of Notch research in adipogenesis has been complicated by
continuous contradictory results, which are often explained by the differences in cell
types and models used by individual investigators. In an attempt to further address
confusion in the field, we also studied the role of Notch1 in hADSC adipogenesis and
found that the loss of Notch1 using targeted siRNA resulted in decreased adipogenesis
six days after adipogenic differentiation. This observation is consistent with other studies,
although the down-regulation of adipogenic markers was not as significant as what we
expected. Upon further investigation, we found that the high expression of Notch1 was
only observed in differentiated preadipocytes, suggesting that six days into adipogenesis
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might not be long enough to fully expose the effect of the Notch1 knockdown. More
importantly, we observed that the nuclear translocation of Notch1 was highly suppressed
during adipogenesis, suggesting that the transcription efficiency of Notch1 was likely to
be lower than other Notch receptors. Indeed, when we knocked down both Notch1 and
Notch3, cells mainly exhibited the effect of the loss of Notch3, indicating that Notch1
and Notch3 are involved in different periods of adipogenesis, respectively, and Notch3
plays a leading role in suppressing early adipogenesis.
The dynamic balance of Notch receptors is another concern that makes Notch a
complex topic in adipogenesis. Assuming that Notch receptors are capable of functionally
compensating for each other, any change in expression of activity of a given Notch
receptor would interfere with the results following the knockdown of the target receptor.
Indeed, we observed an increase in the expression of Notch1 after the knockdown of
Notch3. However, IF staining demonstrated a distinct localization profile for Notch1 and
Notch3, indicating that the increase in the expression of Notch1 was not a result of
intracellular cascades but an indirect result of increased preadipocytes after the
knockdown of Notch3.
Previous research has invested a lot of time and resources into the study of
Notch1 but has not yielded consistent outcomes. We observed that Notch3 not only
functions before Notch1 in adipogenesis, but its inhibitory effect can directly affect the
subsequent regulation of Notch1 during early adipogenesis, indicating the important
position of Notch3 in fat differentiation. On the other hand, we also demonstrated the
dispensability of canonical Notch targets for adipogenic regulation, thus emphasizing the
importance of the non-canonical Notch pathway on adipogenic regulation. Instead, we
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found that Notch3 can enhance the inhibitory effect of Wnt on the commitment of
adipogenesis by protecting -catenin. In summary, we propose that Notch3 may be a
potential therapeutic target for obesity and diabetes in the future.

4.2

Future Directions

The on-going research indicates that Notch is a highly dynamic and contextdependent signaling pathway. Coupled with the complexity of the cell statements during
fat differentiation, the study of Notch in adipogenesis is even more challenging. Here we
will briefly explain the origin of the research difficulties and possible solutions.
Given that the differentiation status of hADSCs are highly heterogeneous during
early adipogenesis, the cascades that determine cell fate are challenging to isolate. In
addition, as a boundary determinate, the activity status of Notch may be completely
opposite in adjacent cells, increasing the difficulty in making universal conclusions
related to the role of this pathway in certain cellular processes. Therefore, looking for a
technique to define and separate cells that are at different stage of adipogenesis is critical
for the study of Notch. For instance, using fluorescence activated cell sorting (FACS) to
separate cells is a default strategy for accomplishing the study of both mRNA and
protein. However, since the size of differentiating cells increases from 10 m to over 100
m, and the laser is potentially randomly reflected by the variation of lipid vesicles in
each cell, setting up a reliable default gate may be challenge. Alternatively, if focusing
on transcription, single-cell RNA sequencing is a powerful technique to isolate and
investigate the downstream transcriptional effect of Notch receptors in each individual
cell. Finally, to gain a better understanding of Notch at the protein level, a microscope

74
with higher resolution is required to expose the detailed distribution of Notch receptors
and interaction with specific proteins at the level of a single cell.
For the study of Notch3, we have determined the positive correlation between
Notch3 and active -catenin during early adipogenesis. Co-IPs demonstrated the proteinprotein interaction of these two molecules. However, these outcomes do not answer the
question of how Notch3 positively regulates the level of -catenin. For instance, whether
there are other proteins involved in the binding of Notch3 and -catenin has not been
confirmed. Also, since -catenin is rapidly ubiquitinated after phosphorylation, if the
Notch3/-catenin interaction prohibits phosphorylation or simply slows the degradation
of -catenin requires further investigation.
The study of Notch1 is still on-going. Our study begins to explain the weak
regulatory effect of Notch1 with its late expression and poor nuclear translocation during
adipogenesis. However, the mechanism for Notch1 to promote the expression of
PPAR still remains unknown. We observed decreased GSK3 after the knockdown of
Notch1but there was no effect on the level of -catenin. As there are multiple targets that
are phosphorylated by GSK3 we believe that investigating the activity of GSK3
substrates is a way to explain the positive relationship between Notch1 and adipogenesis.
On the other hand, since Notch1 is highly expressed during late adipogenesis, we believe
that Notch1 is more involved in the lipid metabolism but not commitment of
adipogenesis. Indeed, it was reported that Notch1 promoted hepatosteatosis by activating
mTorc1, a functional substrate of insulin/Akt pathway (Li et al., 2010; Pajvani et al.,
2013). Whether this cascade is active during hADSC adipogenesis is yet another area for
future investigation.
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The fight against obesity has lasted decades, but the understanding is still
insufficient to relieve weight gain at the clinical level. With the increase in research, the
importance of Notch in metabolic regulation has begun to be revealed. However, since
the focus on Notch1 leaves many questions, Notch is still regarded as an emerging target
in adipogenic regulation. Therefore, increasing research on other receptors has become a
breakthrough in deepening the understanding of Notch in adipogenesis. With continuous
study, the canonical and non-canonical Notch pathway is expected to become a powerful
target for the treatment of human metabolic disease.
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